{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import json\n",
    "import numpy as np\n",
    "from rouge import Rouge\n",
    "from sklearn.utils import resample\n",
    "import matplotlib.pyplot as plt\n",
    "import re\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Load ground truth data from a JSON file\n",
    "with open('data/ground_truth.json', 'r') as f:\n",
    "    records = json.load(f)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'filename': 'Ryan Case 2.txt',\n",
       "  'language': 'english',\n",
       "  'transcription': \"Speaker Guest-1: Hello. Hi, Doctor Way. Hi there. It's nice to meet you. Nice to meet you too. How can I help?\\nSpeaker Guest-2: You today I'm looking for a prescription refill for two of my medications.\\nSpeaker Guest-1: OK. Sounds good. I'm certainly happy to help with that. If you could just let me know the names of your two medications as well as the dosages you take that.\\nSpeaker Guest-2: Yep. So the first one is Ramipril and I take 10 milligrams.\\nSpeaker Guest-2: Daily. Mm-hmm. And then the second one that I'm looking for is Crestor. And again, that's 10 milligrams daily.\\nSpeaker Guest-1: OK. Sounds good. And I'm guessing the ramipril you take it for blood pressure management and then the Crestor you take it for cholesterol?\\nSpeaker Guest-2: Yes, that's right.\\nSpeaker Guest-1: Sounds good, and roughly how long have you been taking these medications for?\\nSpeaker Guest-2: Both for five years.\\nSpeaker Guest-1: OK. All right.\\nSpeaker Guest-1: Any side effects with these dosages?\\nSpeaker Guest-2: Nope.\\nSpeaker Guest-1: No. OK. And do you remember when the last time you had any blood work done was?\\nSpeaker Guest-2: I think it was about six months ago and it came back normal.\\nSpeaker Guest-2: Oh, perfect. All right, so fairly recent and nothing of concern there. And do you happen to check your blood pressure at home?\\nSpeaker Guest-2: I do, it was probably about a month ago that I did it though.\\nSpeaker Guest-1: OK, do do you remember what the number was?\\nSpeaker Guest-2: It was 130 / 80.\\nSpeaker Guest-1: OK, perfect that, that's actually a pretty healthy number. So all good there. And then just checking in with with regards to your blood pressure, have you had any unusual symptoms lately? So things like having really bad headaches, blurry vision, chest pain, shortness of breath or palpitations?\\nSpeaker Guest-2: No, no, no.\\nSpeaker Guest-1: OK, good.\\nSpeaker Guest-1: And then in terms of your past medical history, do you have any other chronic issues I should be aware of?\\nSpeaker Guest-2: I do have high blood pressure and cholesterol.\\nSpeaker Guest-1: OK, that that's all.\\nSpeaker Guest-1: Yeah, that's all. And then any other medications that I should be aware of?\\nSpeaker Guest-2: No, just the two medications that I'm hoping to get a refill on.\\nSpeaker Guest-1: Sounds good and any allergies?\\nSpeaker Guest-2: No allergies? No.\\nSpeaker Guest-1: Awesome. So perfect, fairly straightforward here. So it sounds like you're you're doing well with your with your two medications.\\nSpeaker Guest-1: Been stay stable on the same dosages for many years.\\nSpeaker Guest-1: So I'll go ahead and submit a refill for you today. So one thing to keep in mind just with blood, with blood pressure monitoring, we always recommend checking this regularly at home if you want to do it, not necessarily like every single day, but maybe once every week or so. And then the target that we usually try to aim for just for your awareness is to keep it below about 135 / 85.\\nSpeaker Guest-1: So if you do ever find that it's persistently higher than that, please make sure you speak to to a doctor to assess it. And then this is more of a rare situation, but if you ever notice your blood pressure super high, we're talking above 180 / 110, that would be a reason to just go into an emergency room. Or if you're feeling any of those unusual symptoms like really bad headache, blurry vision, chest pain, shortness of breath.\\nSpeaker Guest-1: With the high blood pressure those those are all possible signs of a more concerning condition there. So before today sounds like you're doing well. So we'll we'll continue these medications at the same dosages and these will be faxed to your pharmacy shortly.\\nSpeaker Guest-2: Great. Awesome. Thank you so much, Doctor Way.\\nSpeaker Guest-1: You're welcome and just make sure you follow up before you run out of you you run out of these medications the next time.\\nSpeaker Guest-2: Sounds good, I will make a note to myself.\\nSpeaker Guest-1: Perfect. All right. Hope you have a great.\\nSpeaker Guest-2: Day you too.\\nSpeaker Unknown: \\nSpeaker Unknown:\",\n",
       "  'soap_note': 'S:\\n\\t•\\tPatient looking for refills on 2 medications\\n\\t•\\tRamipril 10mg daily (taking for high blood pressure)\\n\\t•\\tCrestor 10mg daily (taking for high cholesterol)\\n\\t•\\tPatient has been on both medications for >5 years\\n\\t•\\tDoses are stable, no side effects\\n\\t•\\tMost recent bloodwork completed 6 months ago, unremarkable\\n\\t•\\tMost recent BP check was about a month ago: BP 130/80\\n\\t•\\tFeels well overall, denies any headaches, blurry vision, chest pain, shortness of breath, or palpitations\\n\\t•\\tPast medical history: high blood pressure, high cholesterol\\n\\t•\\tMeds: Ramipril 10mg daily, Crestor 10mg daily\\n\\t•\\tAllergies: none\\nO:\\n\\t•\\tPatient appears well, alert and oriented, and not in any acute distress\\nA:\\n\\t•\\tHypertension, dyslipidemia\\nP:\\n\\t•\\tSince patient is doing well on both medications, agreed to refill both today for 3 months\\n\\t•\\tAdvised to continue monitoring BP regularly at home, seek care if persistently elevated >135/85\\n\\t•\\tReviewed red flags, including severely elevated BP >180/110, or high blood pressure associated with headache, blurry vision, chest pain, shortness of breath, or palpitations - patient aware to attend the Emergency Department if any of the above\\n\\t•\\tFollow-up before medications run out, or sooner if new concerns arise',\n",
       "  'llm_soap_note': 'Subjective:\\n- Patient is requesting a prescription refill for two medications: Ramipril 10 mg daily and Crestor 10 mg daily.\\n- No side effects reported from these medications.\\n- Last blood work was done six months ago and results were normal.\\n- Blood pressure was checked at home about a month ago, reading 130/80.\\n- No unusual symptoms such as headaches, blurry vision, chest pain, shortness of breath, or palpitations reported.\\n\\nPast Medical History:\\n- High blood pressure and cholesterol.\\n- No allergies.\\n\\nObjective:\\n- N/A\\n\\nAssessment:\\n- Stable management of high blood pressure and cholesterol with current medication regimen.\\n\\nPlan:\\n- Refill prescriptions for Ramipril 10 mg daily and Crestor 10 mg daily.\\n- Advise patient to monitor blood pressure regularly at home, aiming for a target below 135/85.\\n- Instruct patient to seek medical attention if blood pressure exceeds 180/110 or if experiencing concerning symptoms.\\n- Follow up before running out of medications.',\n",
       "  'parsed_soap_note': {'Subjective': '•\\tPatient looking for refills on 2 medications\\n\\t•\\tRamipril 10mg daily (taking for high blood pressure)\\n\\t•\\tCrestor 10mg daily (taking for high cholesterol)\\n\\t•\\tPatient has been on both medications for >5 years\\n\\t•\\tDoses are stable, no side effects\\n\\t•\\tMost recent bloodwork completed 6 months ago, unremarkable\\n\\t•\\tMost recent BP check was about a month ago: BP 130/80\\n\\t•\\tFeels well overall, denies any headaches, blurry vision, chest pain, shortness of breath, or palpitations\\n\\t•\\tPast medical history: high blood pressure, high cholesterol\\n\\t•\\tMeds: Ramipril 10mg daily, Crestor 10mg daily\\n\\t•\\tAllergies: none',\n",
       "   'Objective': '•\\tPatient appears well, alert and oriented, and not in any acute distress',\n",
       "   'Assessment': '•\\tHypertension, dyslipidemia',\n",
       "   'Plan': '•\\tSince patient is doing well on both medications, agreed to refill both today for 3 months\\n\\t•\\tAdvised to continue monitoring BP regularly at home, seek care if persistently elevated >135/85\\n\\t•\\tReviewed red flags, including severely elevated BP >180/110, or high blood pressure associated with headache, blurry vision, chest pain, shortness of breath, or palpitations - patient aware to attend the Emergency Department if any of the above\\n\\t•\\tFollow-up before medications run out, or sooner if new concerns arise'},\n",
       "  'parsed_llm_soap_note': {'Subjective': '- Patient is requesting a prescription refill for two medications: Ramipril 10 mg daily and Crestor 10 mg daily.\\n- No side effects reported from these medications.\\n- Last blood work was done six months ago and results were normal.\\n- Blood pressure was checked at home about a month ago, reading 130/80.\\n- No unusual symptoms such as headaches, blurry vision, chest pain, shortness of breath, or palpitations reported.\\n\\nPast Medical History:\\n- High blood pressure and cholesterol.\\n- No allergies.',\n",
       "   'Objective': '- N/A',\n",
       "   'Assessment': '- Stable management of high blood pressure and cholesterol with current medication regimen.',\n",
       "   'Plan': '- Refill prescriptions for Ramipril 10 mg daily and Crestor 10 mg daily.\\n- Advise patient to monitor blood pressure regularly at home, aiming for a target below 135/85.\\n- Instruct patient to seek medical attention if blood pressure exceeds 180/110 or if experiencing concerning symptoms.\\n- Follow up before running out of medications.'}},\n",
       " {'filename': 'Ryan Case 1.txt',\n",
       "  'language': 'english',\n",
       "  'transcription': \"Speaker Guest-1: OK, cool. I'm ready. OK. Hi there. Hi, Doctor Wang. Hey. It's nice to meet you.\\nSpeaker Guest-2: Nice to meet you too.\\nSpeaker Guest-3: So if you can just tell me in in a sentence or two, what brings you here today?\\nSpeaker Guest-1: You know, I was playing. I had a soccer game yesterday.\\nSpeaker Guest-1: And I hurt my foot. It's really painful.\\nSpeaker Guest-1: It was while I was playing.\\nSpeaker Guest-1: And I had to come off the field and yeah, it's just really, really sore.\\nSpeaker Guest-3: Oh, I'm sorry to hear that. Can you tell me a little bit more more about this like so, So First off, which foot is it on?\\nSpeaker Guest-1: It's my left, my left foot.\\nSpeaker Guest-1: Left foot. OK. And do you happen to remember what the mechanism was when you injured it?\\nSpeaker Guest-1: Yeah. Oh, so I oh, you know what? I stepped on someone else's foot.\\nSpeaker Guest-1: And then, yeah, my ankle rolled inwards.\\nSpeaker Guest-3: Oh, OK. So sounds like probably a sprain, hey.\\nSpeaker Guest-3: Yeah, I think so. Or it's broken, I don't know.\\nSpeaker Guest-3: And in terms of the discomfort you're feeling now, whereabouts is is it localized too?\\nSpeaker Guest-1: It feels like it's on the outside of my ankle.\\nSpeaker Guest-3: OK. All right. And after you, you had to come off the field, were you able to walk around or put any weight on your foot at all?\\nSpeaker Guest-1: I can, yeah, but I'm walking with a bit of a limp now.\\nSpeaker Guest-3: Was there any other part of your lower extremity that was affected? So do you have any pain like elsewhere on your feet or in your legs? Your knee?\\nSpeaker Guest-1: No, no pain elsewhere.\\nSpeaker Guest-3: OK. And do you feel any numbness or or weakness? So like any numbness in your toes or difficulty moving the the leg? Nope. OK, all right.\\nSpeaker Guest-3: Well, I think it would be helpful if I'm able to just take a look at your, your foot on the video here. So if you wouldn't mind just flipping your camera around and and show me your foot. Yep.\\nSpeaker Guest-1: Sounds good.\\nSpeaker Guest-3: All right.\\nSpeaker Guest-3: So from what I can see, there's some swelling and bruising around the lateral aspects of your your left ankle, which makes sense given the way that it turned when you you injured it.\\nSpeaker Guest-3: I'm wondering if you can just move your footer around a bit. So, so up and down, left and right. OK, All right. Yeah, it looks like your range of motion is a little bit limited there, which is understandable. And the the next thing I'm going to get you to do is just to press on a few different spots for me, OK?\\nSpeaker Guest-3: So the the first area is on the outside of your foot where where it's probably most, most painful and swollen. There's a Bony protrusion on on the ankle. If you can just press down on that, is it tender when you when you press there?\\nSpeaker Guest-1: No, not really.\\nSpeaker Guest-3: OK, all right, the next.\\nSpeaker Guest-1: Actually, yes.\\nSpeaker Guest-3: That's that's helpful to know and if I can get you to move to.\\nSpeaker Guest-3: If you go along the sole of your foot, so about halfway up the foot, you'll feel another Bony protrusion. This is called the base of your 5th metatarsal. Any pain there?\\nSpeaker Guest-1: No.\\nSpeaker Guest-3: No pain. Good, good. And the last spot I'll get you to press, it's at the very top of your foot. So kind of that the highest point you can you can touch.\\nSpeaker Guest-3: On the sort of in the mid foot area, it's called the navicular. Any pain there?\\nSpeaker Guest-1: No, no pain.\\nSpeaker Guest-3: There.\\nSpeaker Guest-3: OK, good. All right. And before I before I get into what I think this might be and and what we should do for it, just a few more questions to round out your medical history here. So do you have any chronic conditions I should be aware?\\nSpeaker Guest-1: Of yeah, I do have asthma.\\nSpeaker Guest-3: OK. And is it pretty well controlled or very struggling? Yeah.\\nSpeaker Guest-1: Yeah, I think.\\nSpeaker Guest-1: So.\\nSpeaker Guest-3: Do you? Are you using any prescription medications regularly?\\nSpeaker Guest-1: Yeah, I have an inhaler that I use roughly one puff daily.\\nSpeaker Guest-3: OK, good. And do you have any allergies to medications?\\nSpeaker Guest-1: I'm allergic to penicillin.\\nSpeaker Guest-3: OK. Do you know what kind of?\\nSpeaker Guest-3: Reaction it is.\\nSpeaker Guest-1: It's pretty mild.\\nSpeaker Guest-3: OK. All right. I'll make a note of that in your chart. So we make sure it's never prescribed for you. And sorry, I think one thing I need to clarify is just with the inhaler that you use, do you do you remember the name it's called?\\nSpeaker Guest-1: Oh, it's a symbicort.\\nSpeaker Guest-3: OK. Yeah, Yeah, you got it. OK. All right. So I'll add that to your chart as well. All right. So you know, based on our assessment here, I think you you definitely have have an injury to your left ankle and it sounds like it was an inversion injury. So which can often result in a sprain of the ligaments there. But of course like you pointed out earlier.\\nSpeaker Guest-3: But we do want to make sure that this is not anything more concerning like a fracture. So some of the maneuvers I was getting you to do and, and to press around on, on, on your foot was to check for areas that can commonly be fractured in this type of injury. I think overall, like my index of suspicion is relatively low because you are able to walk around and put weight on it, which is always an encouraging sign.\\nSpeaker Guest-3: But you, you did have some tenderness around the, it's called the lateral malleolus. They're just on the outside of the ankle where that bone is.\\nSpeaker Guest-3: So what I'll do here is I will generate a requisition just for a walk in X-ray and I will get, I will get our office to send it into the closest imaging facility to you. And then that way you can go in and get it done within the next day or so and hopefully just to rule out any acute fractures there. Does that all sound good, make sense to you?\\nSpeaker Guest-1: Yeah, that's great, Doctor Wade.\\nSpeaker Guest-3: Thank you. Perfect.\\nSpeaker Guest-3: In terms of things you can do at home in the meantime, just continue with icing it if you haven't already been and try to stay off it as much as you can while it's recovering. Some compression and elevation can be helpful as well, just to decrease the swelling there, OK.\\nSpeaker Guest-1: Sounds good, all right.\\nSpeaker Guest-3: Alright, no problem, Take care.\\nSpeaker Unknown: OK, I think we probably need to stop this recording.\",\n",
       "  'soap_note': \"S:\\n\\t•\\tPatient injured left ankle while playing soccer yesterday\\n\\t•\\tMechanism of injury: stepped on someone else's foot, causing ankle to roll inward\\n\\t•\\tPain localized to outer part of ankle\\n\\t•\\tAble to weight bear and walk around (with a limp) after injury\\n\\t•\\tNo pain elsewhere on the foot, leg, or knee\\n\\t•\\tNo numbness/weakness in the lower extremity\\n\\t•\\tPast medical history: asthma (well-controlled)\\n\\t•\\tMeds: Symbicort inhaler, 1 puff daily\\n\\t•\\tAllergies: Penicillin (mild reaction)\\nO:\\n\\t•\\tPatient appears well, alert and oriented, and not in any acute distress\\n\\t•\\tSwelling and bruising noted to lateral aspect of left ankle\\n\\t•\\tRange of motion limited due to swelling/pain\\n\\t•\\tPatient reports tenderness when pressing on lateral malleolar zone\\n\\t•\\tNo tenderness at the base of 5th metatarsal or navicular areas\\nA:\\n\\t•\\tInversion injury to left ankle\\nP:\\n\\t•\\tAdvised to continue managing symptoms with rest, ice, compression, and elevation\\n\\t•\\tGiven tenderness in malleolar zone, will order X-ray to rule out fracture\\n\\t•\\tFollow-up on results once available, or sooner if the condition worsens or any new concerns arise\",\n",
       "  'llm_soap_note': \"Subjective:\\n- Patient reports injuring their left foot during a soccer game, resulting in significant pain.\\n- The injury occurred when the patient stepped on another player's foot, causing the ankle to roll inwards.\\n- Pain is localized on the outside of the left ankle.\\n- Patient is able to walk but with a limp.\\n- No pain elsewhere in the lower extremity, no numbness, or weakness reported.\\n\\nPast Medical History:\\n- Asthma, controlled with Symbicort inhaler (one puff daily).\\n- Allergic to penicillin, with a mild reaction.\\n\\nObjective:\\n- Swelling and bruising observed around the lateral aspect of the left ankle.\\n- Limited range of motion noted.\\n- Tenderness present around the lateral malleolus.\\n- No pain at the base of the 5th metatarsal or navicular.\\n\\nAssessment:\\n- Likely sprain of the left ankle due to inversion injury.\\n- Low suspicion of fracture due to the ability to bear weight.\\n\\nPlan:\\n- Investigations planned: Requisition for a walk-in X-ray to rule out any acute fractures.\\n- Treatment planned: Advise icing, rest, compression, and elevation of the ankle to reduce swelling.\\n- Follow-up: Await X-ray results to confirm the absence of fractures.\",\n",
       "  'parsed_soap_note': {'Subjective': \"•\\tPatient injured left ankle while playing soccer yesterday\\n\\t•\\tMechanism of injury: stepped on someone else's foot, causing ankle to roll inward\\n\\t•\\tPain localized to outer part of ankle\\n\\t•\\tAble to weight bear and walk around (with a limp) after injury\\n\\t•\\tNo pain elsewhere on the foot, leg, or knee\\n\\t•\\tNo numbness/weakness in the lower extremity\\n\\t•\\tPast medical history: asthma (well-controlled)\\n\\t•\\tMeds: Symbicort inhaler, 1 puff daily\\n\\t•\\tAllergies: Penicillin (mild reaction)\",\n",
       "   'Objective': '•\\tPatient appears well, alert and oriented, and not in any acute distress\\n\\t•\\tSwelling and bruising noted to lateral aspect of left ankle\\n\\t•\\tRange of motion limited due to swelling/pain\\n\\t•\\tPatient reports tenderness when pressing on lateral malleolar zone\\n\\t•\\tNo tenderness at the base of 5th metatarsal or navicular areas',\n",
       "   'Assessment': '•\\tInversion injury to left ankle',\n",
       "   'Plan': '•\\tAdvised to continue managing symptoms with rest, ice, compression, and elevation\\n\\t•\\tGiven tenderness in malleolar zone, will order X-ray to rule out fracture\\n\\t•\\tFollow-up on results once available, or sooner if the condition worsens or any new concerns arise'},\n",
       "  'parsed_llm_soap_note': {'Subjective': \"- Patient reports injuring their left foot during a soccer game, resulting in significant pain.\\n- The injury occurred when the patient stepped on another player's foot, causing the ankle to roll inwards.\\n- Pain is localized on the outside of the left ankle.\\n- Patient is able to walk but with a limp.\\n- No pain elsewhere in the lower extremity, no numbness, or weakness reported.\\n\\nPast Medical History:\\n- Asthma, controlled with Symbicort inhaler (one puff daily).\\n- Allergic to penicillin, with a mild reaction.\",\n",
       "   'Objective': '- Swelling and bruising observed around the lateral aspect of the left ankle.\\n- Limited range of motion noted.\\n- Tenderness present around the lateral malleolus.\\n- No pain at the base of the 5th metatarsal or navicular.',\n",
       "   'Assessment': '- Likely sprain of the left ankle due to inversion injury.\\n- Low suspicion of fracture due to the ability to bear weight.',\n",
       "   'Plan': '- Investigations planned: Requisition for a walk-in X-ray to rule out any acute fractures.\\n- Treatment planned: Advise icing, rest, compression, and elevation of the ankle to reduce swelling.\\n- Follow-up: Await X-ray results to confirm the absence of fractures.'}},\n",
       " {'filename': 'Sara Case 2.txt',\n",
       "  'language': 'english',\n",
       "  'transcription': \"Speaker Guest-1: Hi John, my name is Sarah. I'm a nurse practitioner that works here at Tele S Virtual Care. How can I help you today? Hey Sarah, nice to meet you. So I've had a cough that's been persistent throughout the day.\\nSpeaker Guest-1: And oh, oops, I've I've had a cough that I've developed and it's been bothering me for the past couple of days.\\nSpeaker Guest-2: OK. And you?\\nSpeaker Guest-1: Said it started a couple of days ago. You would just say about two days ago, yes, All right.\\nSpeaker Guest-1: OK, OK. And.\\nSpeaker Guest-1: You mentioned the cough is persistent, so is it happening all the time or do you find it comes and goes?\\nSpeaker Guest-2: It seems to get worse at night when I'm laying down, but it it is pretty persistent throughout the day.\\nSpeaker Guest-1: OK. And can you describe the cough for me what you described as wet, dry?\\nSpeaker Guest-1: It's dry and frequent OK.\\nSpeaker Guest-1: And are you coughing anything up at all?\\nSpeaker Guest-1: No. OK, I'm just going to review some red flag and general symptoms with you and let me know if you have any of the following. OK. Do you have any chest pain? Shortness of breath? Purulent or dark Sputum. So like a funny color? Bad smell Sputum. No. OK Any coughing up blood? No. OK. Any persistent fever?\\nSpeaker Guest-1: No increase respiratory rate or increase heart rate.\\nSpeaker Guest-1: No any loss of any loss of appetite.\\nSpeaker Guest-1: Any unintentional weight loss.\\nSpeaker Guest-1: And any increased work of breathing, Like do you see your neck tugging in when you're breathing or can you see your ribs every time you take a breath? Do you have any pain when you're breathing or coughing? No pain. No any wheezing or activity intolerance? No. OK. Any difficulty breathing when you lie down?\\nSpeaker Guest-2: No, just that my cough gets worse when I seem to lie down.\\nSpeaker Guest-1: OK. And any stuffy nose or runny nose?\\nSpeaker Guest-1: My I, I do feel a bit congested. OK. And do you have any pain or pressure under your eyes when you press them or above your eyes around your nose a little bit, OK. Any post nasal drip? Yes, I do have that.\\nSpeaker Guest-2: Sorry, did I say that I didn't have a fever? I think I did, but I do have a low grade fever.\\nSpeaker Guest-1: OK, a low grade feature.\\nSpeaker Guest-1: Any chills or headache?\\nSpeaker Guest-2: No, not really. Just the congestion is making me feel a bit heavy in the head, OK.\\nSpeaker Guest-1: OK.\\nSpeaker Guest-1: And any general feeling of discomfort or feeling unwell.\\nSpeaker Guest-2: I've been my my throat is sore.\\nSpeaker Guest-2: And I'm feeling really tired and fatigued.\\nSpeaker Guest-1: OK. Any muscle or joint pain? No, not really. OK. And have you had any known sick contacts?\\nSpeaker Guest-2: Yes, I was at work the other day and my coworker wasn't feeling very well and had very similar symptoms to what I'm feeling now.\\nSpeaker Guest-1: OK. And are you finding that anything is making the cost better?\\nSpeaker Guest-2: I tried some honey and lemon tea and it provided temporary relief and.\\nSpeaker Guest-1: Are you finding anything makes the cough worse? I know you mentioned lying down makes the cough worse, is there anything else?\\nSpeaker Guest-2: Cold air seems to make it worse.\\nSpeaker Guest-1: OK. And have you tried anything to help alleviate the symptoms? I know you mentioned the lemon water and honey, Anything else that you've tried?\\nSpeaker Guest-2: I went to Shoppers Drug Mart and I got some cough syrup, but it hasn't been helping that much.\\nSpeaker Guest-1: OK. And do you know which one you got?\\nSpeaker Guest-1: It was Dextro.\\nSpeaker Guest-1: Mortherfan, OK. Dextromethorphan.\\nSpeaker Guest-1: OK.\\nSpeaker Guest-1: And do you have any underlying medical conditions like asthma, COPD, congestive heart failure, history of choking, heart disease?\\nSpeaker Guest-1: OK, Perfect. And do you have any recurrent exposures at home or work to any chemicals, sprays, dust, pets? Nope. OK. And do you smoke cigarettes or do you have any consistent exposure to secondhand smoke?\\nSpeaker Guest-1: No. OK. Perfect. And do you have any family history of any underlying lung conditions, seasonal allergies?\\nSpeaker Guest-2: Yeah, my dad has seasonal allergies.\\nSpeaker Guest-1: OK. And are you currently taking any medications consistently like over the cancer medications prescribed medications, vitamins or supplements?\\nSpeaker Guest-2: No, just the cough syrup that I had mentioned.\\nSpeaker Guest-1: And any allergies to medications? No allergies. Awesome. OK, so it does sound like this is likely a viral illness, just given that it was such it only started a few days ago and it's a dry cough.\\nSpeaker Guest-1: And your sore throat is?\\nSpeaker Guest-1: All these symptoms are quite consistent with the viral illness. I also took a look at your throat photo and I didn't see anything that was concerning. It definitely looks a little bit red, but your tonsils don't look swollen and I don't see any white spots, which again is quite consistent with a viral illness. Also, you mentioned you have post nasal drip, so the post nasal drip can cause a bit of a sore throat and some irritation.\\nSpeaker Guest-1: So there's a couple things I would recommend. So for the cough, it's really important to stay hydrated.\\nSpeaker Guest-1: You can definitely continue with the lemon water and the honey. Honey is really helpful to soothe your throat to help stop the cough. If you're not finding much of an effect from the cough syrup, then you don't need to take it. If you are finding it helpful, you can continue to take it. Everyone responds differently to it, but it isn't going to get rid of your cough. It will just help to sort of keep it at Bay or help relieve some of the symptoms.\\nSpeaker Guest-1: Because it's viral, it will just go away on its own. Costs especially can last up to.\\nSpeaker Guest-1: 10 days, even longer for some people if you are finding out all that, you're having chest pain, shortness of breath, a lot of wheezing, you're coughing up really gross colored sputum, you're having a fever that won't go away, you're feeling extremely unwell. Those would be reasons to go seek an in person assessment. The chest pain, the shortness of breath are more concerning signs of those that require ER. But if you just have general fever.\\nSpeaker Guest-1: Coughing a lot, your coughing stuff out, you're not feeling well. You could start with just a family doctor's clinic or walk in clinic just to have someone listen to your lungs and see if there's any further assessments that need to be done. And you also mentioned your habits and post nasal drip. So a couple of things that can help with that. So propping your head up a little bit more at night you can.\\nSpeaker Guest-1: Try a saline nasal spray or a saline nasal rinse. The nasal rinse is really important that you use sterile or distilled water, not tap water. You can always take tap water, put it out of running, boil for two minutes.\\nSpeaker Guest-1: And then let it cool to the temperature to use with the saline packs. But tap water can actually increase your risk of a sinus infection. And then a humidifier in your room at night can also really just help to keep everything moisturized because it does get drier at night. You can do throat lozenges like halls or even Cepacol has a bit of a numbing agent in it if your throat is a bit sore and you wanted to try that.\\nSpeaker Guest-1: And then?\\nSpeaker Guest-1: The other thing that we could try if you'd like, I know you mentioned you're having a bit of facial pain and pressure and that post nasal drip as we can try a steroid nasal spray, you would do 2 sprays in each nostril once a day for about 7 days. If you find it's still not 100% gone, you can do it up to 10, but usually seven days is enough to relieve it and that can help prevent leading to an actual bacterial sinus infection.\\nSpeaker Guest-1: Where you need antibiotics it will help dry you up a little bit so that it reduces the post nasal drip. And to use this I would recommend doing the ceiling spray or nasal rinse first and then doing the spray so that it actually gets into your sinuses. Do you have any other questions or anything?\\nSpeaker Guest-2: And I get that just over the counter or is that a prescription?\\nSpeaker Guest-2: So the cereal nasal spray, there is one over the counter but if you have insurance coverage then I would send a prescription and you can get it covered.\\nSpeaker Guest-2: OK. Yeah, that sounds good. OK.\\nSpeaker Guest-1: Perfect. If you don't have any other questions today, then I'll let you go and you can follow up at any point if anything's worsening or you have any other questions or concerns.\\nSpeaker Guest-2: Yeah, that sounds great. Thanks, Sarah.\\nSpeaker Guest-1: No problem, Take care.\\nSpeaker Unknown:\",\n",
       "  'soap_note': 'S:\\n\\nCurrently in ON. Reviewed CM, [insert first initial. Last name here], SOAP note and confirmed info provided. See note for details. \\n\\n27 year old male engaging for a cough\\nOnset: 2 days ago\\nDuration: persistent throughout the day\\nAggravating factors: \\n\\t•\\tCold air\\n\\t•\\tWorse at night when lying down\\nAlleviating factors: \\n\\t•\\thoney and lemon tea provides temporary relief\\nQuality: Dry cough, no sputum production\\nAssociated symptoms:\\n\\t•\\tSore throat\\n\\t•\\tNasal congestion with sinus pain/pressure to frontal and maxillary sinus area, head feels a bit heavy\\n\\t•\\tPost nasal drip\\n\\t•\\tLow-grade fever (self-reported 37.8C) that has now resolved\\n\\t•\\tFatigue\\nRed flags:\\n\\t•\\tNo chest pain\\n\\t•\\tNo shortness of breath\\n\\t•\\tNo wheezing\\n\\t•\\tNo hemoptysis\\n\\t•\\tNo loss of appetite or weight loss\\n\\t•\\tNo tachycardia\\n\\t•\\tNo tachypnea\\nSick contacts: Reports that a coworker had similar symptoms last week\\n\\nTreatments tried:\\n\\t•\\tLemon and honey tea with temporary relief\\n\\t•\\tDextromethorphan cough syrup with minimal effect\\nRelevant health history:\\n\\t•\\tNo known exposures to dust, chemicals, sprays or pets at work or home\\n\\t•\\tNon-smoker, no consistent second-hand smoke exposure\\n\\t•\\tNo history of asthma, COPD, or other chronic respiratory conditions, seasonal allergies\\nFamily history:\\n\\t•\\tFather has seasonal allergies\\nCurrent medications: None reported \\nAllergies: NKA\\n\\nO:\\n\\t•\\tConfirmed ID\\n\\t•\\tNAD, A+Ox3\\n\\t•\\tDressed appropriately, speaking in full sentences\\n\\t•\\tNo SOB, wheezing, muffled voice, excessive drooling noted on VC\\n\\t•\\tThroat photo: provide description here \\n\\nA:\\n\\t•\\tLikely viral upper respiratory tract infection \\n\\nP:\\nAdvised for some concerns, virtual care is not a substitute or replacement for in-person exam. Pt acknowledges this\\n\\nDifferential diagnoses discussed: Viral vs bacterial URTI\\nTreatment plan: \\n\\t•\\tNon-pharmacological options: Fluids, rest, throat lozenges (e.g. Halls or Cepacol), elevate head when sleeping/lying down to reduce postnasal drip, humidifier, saline nasal spray or rinse PRN and prior to steroid nasal spray(provided instructions on proper water to use for rinse - no tap water, only sterile or distilled)\\n\\t•\\tPharmacological option: Rx for nasonex nasal spray sent to pharmacy\\n\\t•\\tReviewed that since symptoms are likely viral, no need for antibiotics at this time\\n\\t•\\tGiven no evidence of bacterial infection in throat (no exudate or swollen tonsils), manage with non-pharmacological options\\n\\t•\\tReviewed red flags including, but not limited to: chest pain, shortness of breath, excessive wheezing, go to ER\\n\\t•\\tIf fever persists, sputum production develops, or patient feels generally unwell with no red flag symptoms, seek in person assessment \\n\\nFollow up as needed; patient can engage 24/7/365 with any concerns.',\n",
       "  'llm_soap_note': 'Subjective:\\n- Chief Complaint: Persistent dry cough for the past two days, worse at night when lying down.\\n- Associated Symptoms: Low-grade fever, congestion, post-nasal drip, sore throat, fatigue, and facial pressure.\\n- Aggravating Factors: Lying down and exposure to cold air.\\n- Alleviating Factors: Temporary relief with honey and lemon tea.\\n- Self-treatment: Tried dextromethorphan cough syrup with little effect.\\n- Social History: Recent contact with a sick coworker exhibiting similar symptoms.\\n- Family History: Father has seasonal allergies.\\n\\nObjective:\\n- Throat examination: Redness observed, no swollen tonsils or white spots.\\n\\nAssessment:\\n- Likely viral illness with symptoms consistent with a viral infection.\\n- Pertinent negatives: No chest pain, shortness of breath, purulent sputum, hemoptysis, persistent fever, increased respiratory or heart rate, loss of appetite, unintentional weight loss, increased work of breathing, pain on breathing or coughing, wheezing, or activity intolerance.\\n\\nPlan:\\n- Continue hydration and use of honey and lemon tea for throat soothing.\\n- Consider discontinuing cough syrup if not effective.\\n- Use saline nasal spray or rinse with sterile/distilled water.\\n- Use a humidifier at night to maintain moisture.\\n- Consider throat lozenges with numbing agents for sore throat relief.\\n- Prescribe or recommend over-the-counter steroid nasal spray for facial pain and post-nasal drip, with instructions to use after saline rinse.\\n- Advise on signs that require further medical assessment, such as persistent or worsening symptoms.\\n- Follow-up if symptoms worsen or new concerns arise.',\n",
       "  'parsed_soap_note': {'Subjective': 'Currently in ON. Reviewed CM, [insert first initial. Last name here], SOAP note and confirmed info provided. See note for details. \\n\\n27 year old male engaging for a cough\\nOnset: 2 days ago\\nDuration: persistent throughout the day\\nAggravating factors: \\n\\t•\\tCold air\\n\\t•\\tWorse at night when lying down\\nAlleviating factors: \\n\\t•\\thoney and lemon tea provides temporary relief\\nQuality: Dry cough, no sputum production\\nAssociated symptoms:\\n\\t•\\tSore throat\\n\\t•\\tNasal congestion with sinus pain/pressure to frontal and maxillary sinus area, head feels a bit heavy\\n\\t•\\tPost nasal drip\\n\\t•\\tLow-grade fever (self-reported 37.8C) that has now resolved\\n\\t•\\tFatigue\\nRed flags:\\n\\t•\\tNo chest pain\\n\\t•\\tNo shortness of breath\\n\\t•\\tNo wheezing\\n\\t•\\tNo hemoptysis\\n\\t•\\tNo loss of appetite or weight loss\\n\\t•\\tNo tachycardia\\n\\t•\\tNo tachypnea\\nSick contacts: Reports that a coworker had similar symptoms last week\\n\\nTreatments tried:\\n\\t•\\tLemon and honey tea with temporary relief\\n\\t•\\tDextromethorphan cough syrup with minimal effect\\nRelevant health history:\\n\\t•\\tNo known exposures to dust, chemicals, sprays or pets at work or home\\n\\t•\\tNon-smoker, no consistent second-hand smoke exposure\\n\\t•\\tNo history of asthma, COPD, or other chronic respiratory conditions, seasonal allergies\\nFamily history:\\n\\t•\\tFather has seasonal allergies\\nCurrent medications: None reported \\nAllergies: NKA',\n",
       "   'Objective': '•\\tConfirmed ID\\n\\t•\\tNAD, A+Ox3\\n\\t•\\tDressed appropriately, speaking in full sentences\\n\\t•\\tNo SOB, wheezing, muffled voice, excessive drooling noted on VC\\n\\t•\\tThroat photo: provide description here',\n",
       "   'Assessment': '•\\tLikely viral upper respiratory tract infection',\n",
       "   'Plan': 'Advised for some concerns, virtual care is not a substitute or replacement for in-person exam. Pt acknowledges this\\n\\nDifferential diagnoses discussed: Viral vs bacterial URTI\\nTreatment plan: \\n\\t•\\tNon-pharmacological options: Fluids, rest, throat lozenges (e.g. Halls or Cepacol), elevate head when sleeping/lying down to reduce postnasal drip, humidifier, saline nasal spray or rinse PRN and prior to steroid nasal spray(provided instructions on proper water to use for rinse - no tap water, only sterile or distilled)\\n\\t•\\tPharmacological option: Rx for nasonex nasal spray sent to pharmacy\\n\\t•\\tReviewed that since symptoms are likely viral, no need for antibiotics at this time\\n\\t•\\tGiven no evidence of bacterial infection in throat (no exudate or swollen tonsils), manage with non-pharmacological options\\n\\t•\\tReviewed red flags including, but not limited to: chest pain, shortness of breath, excessive wheezing, go to ER\\n\\t•\\tIf fever persists, sputum production develops, or patient feels generally unwell with no red flag symptoms, seek in person assessment \\n\\nFollow up as needed; patient can engage 24/7/365 with any concerns.'},\n",
       "  'parsed_llm_soap_note': {'Subjective': '- Chief Complaint: Persistent dry cough for the past two days, worse at night when lying down.\\n- Associated Symptoms: Low-grade fever, congestion, post-nasal drip, sore throat, fatigue, and facial pressure.\\n- Aggravating Factors: Lying down and exposure to cold air.\\n- Alleviating Factors: Temporary relief with honey and lemon tea.\\n- Self-treatment: Tried dextromethorphan cough syrup with little effect.\\n- Social History: Recent contact with a sick coworker exhibiting similar symptoms.\\n- Family History: Father has seasonal allergies.',\n",
       "   'Objective': '- Throat examination: Redness observed, no swollen tonsils or white spots.',\n",
       "   'Assessment': '- Likely viral illness with symptoms consistent with a viral infection.\\n- Pertinent negatives: No chest pain, shortness of breath, purulent sputum, hemoptysis, persistent fever, increased respiratory or heart rate, loss of appetite, unintentional weight loss, increased work of breathing, pain on breathing or coughing, wheezing, or activity intolerance.',\n",
       "   'Plan': '- Continue hydration and use of honey and lemon tea for throat soothing.\\n- Consider discontinuing cough syrup if not effective.\\n- Use saline nasal spray or rinse with sterile/distilled water.\\n- Use a humidifier at night to maintain moisture.\\n- Consider throat lozenges with numbing agents for sore throat relief.\\n- Prescribe or recommend over-the-counter steroid nasal spray for facial pain and post-nasal drip, with instructions to use after saline rinse.\\n- Advise on signs that require further medical assessment, such as persistent or worsening symptoms.\\n- Follow-up if symptoms worsen or new concerns arise.'}},\n",
       " {'filename': 'Sara Case 1.txt',\n",
       "  'language': 'english',\n",
       "  'transcription': \"Speaker Guest-1: OK.\\nSpeaker Guest-2: Which I started like a real consult.\\nSpeaker Guest-2: You have to do like the privacy stuff like the introduce myself.\\nSpeaker Guest-2: Hi Rebecca, my name is Sarah. I'm a nurse practitioner that works here at Telehealth virtual Care. How can I help you today?\\nSpeaker Guest-3: Hi Sarah, I've actually I have acne and it's been getting worse over the past few months and my usual skin care routine doesn't seem to be working.\\nSpeaker Guest-2: OK. And when did it start?\\nSpeaker Guest-3: It started gradually getting worse over the last eight months, but it significantly flared up in the last three months.\\nSpeaker Guest-2: And where specifically is your acne located?\\nSpeaker Guest-3: It's concentrated on my jawline and chin, but I do have some lesions on my cheeks and upper back.\\nSpeaker Guest-2: OK. And is this the first time that you've ever had acne or have you had acne in the past?\\nSpeaker Guest-3: No, I've definitely had it in the past. I've had it since I was a teen. But the current episode has been intermittent for the past eight months. OK.\\nSpeaker Guest-3: And do you find that there's anything that makes your acne better?\\nSpeaker Guest-3: No.\\nSpeaker Guest-3: OK. And have you seen that there's anything that makes it worse?\\nSpeaker Guest-3: It seems to be worse around my menstrual cycle and when I'm stressed from school, but I've recently switched to a new moisturizer.\\nSpeaker Guest-2: OK. And which moisturizer are you using?\\nSpeaker Guest-3: I am using Sarah vape. Oh I'm using a cleanser Cerave. I think my moisturizer is the same and it has SPF 30 in it. OK cool.\\nSpeaker Guest-2: And approximately if you had to estimate, how many lesions do you think you have on average when you get these flare ups?\\nSpeaker Guest-3: 1515 to 20 I would say OK.\\nSpeaker Guest-3: And when you?\\nSpeaker Guest-2: Get these flare ups. Do you have any of the following characteristics at all? Like would you classify the acne as cystic?\\nSpeaker Guest-2: Do you notice any white heads or inflammation or inflammatory, We call them inflammatory papules. They're like little bumps that are really red.\\nSpeaker Guest-2: Pus that comes out of them, Any hard nodules? Is it really painful?\\nSpeaker Guest-3: Yeah, I definitely do notice some bumps. I have a bit of redness.\\nSpeaker Guest-3: On my cheeks.\\nSpeaker Guest-3: And it's like so noticeable that it's like giving me anxiety to be out in public.\\nSpeaker Guest-2: OK. And I know we talked a little bit about your moisturizer already, but what is your current skin care routine look like?\\nSpeaker Guest-3: So I'm just washing my face with Survey, which is that foam cleanser that I mentioned. I use a retinol serum in the evening and then apply moisturizer. But yeah, during the day my moisturizer is SPF 30. OK, perfect.\\nSpeaker Guest-2: And do you have any underlying medical conditions, things like PCOS? Have you ever been told that you have elevated blood sugars, high blood pressure, any cholesterol issues?\\nSpeaker Guest-2: Nope. Nope, none of those. Any medications that you think might be triggering your acne?\\nSpeaker Guest-3: No, but I have taken.\\nSpeaker Guest-3: Benzoyl peroxide at 5%.\\nSpeaker Guest-3: And.\\nSpeaker Guest-2: Salicylic acid products, I'm kind of aside from that, I haven't had those are all over the counter and I haven't had any other previous prescription treatments. OK, perfect. And I'm just going to ask you a couple of questions regarding your reproductive health just so that I can make sure any treatments that Ioffer are safe to be given. Is that OK? OK. And when was the last, when was the first day of your last period?\\nSpeaker Guest-3: November 28th.\\nSpeaker Guest-2: OK. And is there any concern about being pregnant?\\nSpeaker Guest-3: Nope. OK.\\nSpeaker Guest-2: And are you breastfeeding? I'm not. And have you ever been on birth control in the past? No, I haven't. And I know you mentioned previous treatments for the benzyl peroxide and the salicylic acid.\\nSpeaker Guest-2: Are you currently taking any medications? You mentioned you're using a retinol with that over the counter, OK. Are you taking any other medications over the counter prescribed vitamins or supplements?\\nSpeaker Guest-3: Yes, I'm taking a multivitamin but nothing else. OK.\\nSpeaker Guest-2: And do you have any allergies to medications?\\nSpeaker Guest-3: No, no allergies.\\nSpeaker Guest-2: Perfect. OK, so.\\nSpeaker Guest-2: Based on everything that you've mentioned to me, it does sound like you have closer to the moderate side, somewhere between mild and moderate.\\nSpeaker Guest-2: Acne and you mentioned you have bumps and some redness to your cheek.\\nSpeaker Guest-2: Do you ever notice that you get You can make this up if you get flushed when you're really hot or if you're drinking any alcohol.\\nSpeaker Guest-3: Yes, I do notice, particularly with alcohol, I noticed that.\\nSpeaker Guest-3: OK.\\nSpeaker Guest-3: And then I feel like it acts up when I'm like exercising as well.\\nSpeaker Guest-2: OK, so there could be a little bit of a rosacea component to this as well, but it definitely sounds like you're having some acne to the chin, jaw line in the cheek area.\\nSpeaker Guest-2: And it also sounds like it fluctuates and it's worse during your period, the time of your period. So there can be a little bit of a hormonal component to it as well.\\nSpeaker Guest-2: So first of all, it's really important that you are cleansing your face properly. So the products that you use, Seraphine is a very well known dermatological.\\nSpeaker Guest-2: Recommended option so you can definitely continue with the products that you're using. I know you mentioned you you you started using a new moisturizer recently. It's possible that this moisturizer could be irritating your skin and causing some of that breakout. So if you have used a different moisturizer in the past that didn't cause a breakout, you could try that one.\\nSpeaker Guest-2: In general, Cerave, Cetaphil, those are pretty well tolerated moisturizers, but everyone's skin is slightly different so sometimes it's trial and error.\\nSpeaker Guest-2: It's really important to use a non communogenic moisturizer so that we can avoid breakouts. If your skin is more on the dry side, it might be helpful to just wash your face once a day like in the evening and just use water in the morning just to avoid it getting overly dry, especially in the winter.\\nSpeaker Guest-2: And then in terms of treatment, so my typical go to for starting treatment is something topical because you're sort of in that mild to moderate range.\\nSpeaker Guest-2: And you might need more of a combination product. And I know you mentioned you tried benzoyl peroxide and salicylic acid on their own without much effect, but it might be helpful if we do a combination where we do, we can do a combination of a benzoyl peroxide and an antibiotic or a, sorry, an antibiotic and a retinoid combination. And the one nice thing about the retinoid is it will help to reduce some of that redness, more of that inflammation, reduce the risk of scarring.\\nSpeaker Guest-2: Umm, so that would be a recommendation that I have for you since you have a little bit more of the hormonal stress related acne. I think I would go with the combo retinoid and benzoyl peroxide as opposed to the antibiotic one to start. But again, everyone responds slightly differently to acne treatment so it is a little bit of trial and error and there are a lot of options.\\nSpeaker Guest-2: The other option could be an oral contraceptive if we want to regulate your hormones. I'm not sure how you feel about starting an oral contraceptive, but that is always an option if you didn't want to go the topical route.\\nSpeaker Guest-2: Or we tried the topical route and you're not happy with the results.\\nSpeaker Guest-2: OK, that sounds good. I think I'll try the topical route first and then maybe if that's not working I can explore.\\nSpeaker Guest-2: The the birth control route now, of course. OK, so the one that I would recommend is the tac tube pump. It's a combination of a retinoid and a benzoyl peroxide. It can be really irritating to the skin when you first start. So the recommendation I have is to use it either every other day or every three days at night and at a pea size amount every night.\\nSpeaker Guest-2: Sorry, every other night or every three nights and see how your skin reacts to it and work your way up to every night as you start to tolerate it more and more. Make sure you're applying a lot of moisturizer to keep your skin hydrated. And it's really important that you're continuing with that SPF sunscreen because it can make your skin a little bit more sensitive to the sun. And if you ever have any concerns or you're feeling like it's not working, you can let us know. It is really important to remember it can take at least three months for us to really start to see an effect of these medications, so.\\nSpeaker Guest-2: It's just important to be patient, but if you still want to change or you're not happy with the results, we can always reassess.\\nSpeaker Guest-3: OK. That sounds great. OK, OK. Thanks, Sarah.\\nSpeaker Unknown: No problem, Take care.\",\n",
       "  'soap_note': 'S:\\n\\nCurrently in ON. Reviewed CM, [insert first initial. Last name here], SOAP note and confirmed info provided. See note for details. \\n\\n22 year old female engaging for acne concerns\\n\\nOnset: has had ance since teens, but current flare-up started 8 months ago with a gradual worsening over the past 3 months \\nLocation: Primarily to jawline and chin, with some lesions to cheeks and upper back\\nAggravating factors: \\n\\t•\\tworsens around the time of menstruation and during periods of increased stress from school\\n\\t•\\tRecently switched to a new Cerave moisturizer\\nAlleviating factors: none\\nSeverity: 15-20 inflammatory papules and pustules \\nAssociated symptoms/characteristics: \\n\\t•\\tReports some hyperpigmentation/redness to cheeks\\n\\t•\\tReports feels anxious about going out in public due to appearance of acne \\n\\nCurrent skin care routine:\\n\\t•\\tAM: Cerave foaming cleanser, moisturizer with SPF\\n\\t•\\tPM: Cerave foaming cleanser, OTC retinol serum, cerave moisturizer\\nPrevious treatments tried:\\n\\t•\\tOTC: Benzoyl peroxide 5%, salicylic acid products\\n\\t•\\tNo previous rx treatments tried\\nReproductive history:\\n\\t•\\tLMP: Nov. 28, 2024\\n\\t•\\tPregnancy concerns: None\\n\\t•\\tCurrently breastfeeding: No\\n\\t•\\tNo history of prescribed birth control use \\nRelevant history:\\n\\t•\\tNo underlying medical conditions\\n\\t•\\tCurrent medications: Multivitamin\\n\\t•\\tNKA (= abbreviation for no known allergies)\\n\\nO:\\n\\t•\\tConfirmed ID\\n\\t•\\tNAD, A+Ox3\\n\\t•\\tDressed appropriately, speaking in full sentences\\n\\t•\\tSkin photo: provide description here\\n\\nA:\\n\\t•\\tMild to moderate papulopustular acne\\n\\nP:\\nAdvised for some concerns, virtual care is not a substitute or replacement for in-person exam. Pt acknowledges this\\n\\nDifferential diagnoses discussed: Rosacea vs acne\\nTreatment plan: \\n\\t•\\tContinue with Cerave foaming cleanser. Can decrease to QHS use only and water only in am if experiencing skin dryness\\n\\t•\\tConsider changing moisturizers back to what was previously used, if no acne at the time of use. Ensure it is non-comedogenic\\n\\t•\\tDiscussed treatment options with patient - topical vs oral contraception. Pt prefers to start with topical route. Rx for Tactupump sent to pharmacy on file. Discussed Tactupump can cause skin irritation if applied too frequently. Pt to start with applying tactupump Q2-3 nights before bed and slowly increase to QHS, as tolerated. Apply moisturizer after. Pt aware it can take up to 3 months to start seeing results\\n\\nFollow up if symptoms not improving and/or resolving as expected and especially if worsening; patient can engage 24/7/365 with any concerns.',\n",
       "  'llm_soap_note': \"Subjective:\\n- Chief Complaint: Acne worsening over the past few months.\\n- Duration: Gradual worsening over the last eight months, significant flare-up in the last three months.\\n- Location: Concentrated on jawline and chin, with some lesions on cheeks and upper back.\\n- Previous Episodes: Has had acne since teenage years, current episode intermittent for the past eight months.\\n- Aggravating Factors: Worse around menstrual cycle and during stress from school; possibly related to new moisturizer.\\n- Associated Symptoms: Bumps and redness on cheeks, noticeable enough to cause anxiety in public.\\n- Skin Care Routine: Uses Cerave foam cleanser, retinol serum in the evening, and moisturizer with SPF 30.\\n- Previous Treatments: Benzoyl peroxide 5% and salicylic acid products, no previous prescription treatments.\\n- Reproductive Health: Last menstrual period on November 28th, no concern about pregnancy, not breastfeeding, never been on birth control.\\n- Medications: Retinol (over the counter), multivitamin.\\n- Allergies: No known allergies.\\n- Social History: Stress from school.\\n\\nPast Medical History:\\n- No underlying medical conditions such as PCOS, elevated blood sugars, high blood pressure, or cholesterol issues.\\n\\nObjective:\\n- N/A\\n\\nAssessment:\\n- Moderate acne with hormonal and stress-related components.\\n- Possible rosacea component due to flushing with alcohol and exercise.\\n\\nPlan:\\n- Treatment: Start with a topical combination of retinoid and benzoyl peroxide (Tac tube pump). Use every other day or every three days at night, gradually increasing to nightly use as tolerated. Apply a pea-sized amount and ensure adequate moisturizing.\\n- Skin Care: Continue using non-comedogenic moisturizer and SPF 30 sunscreen.\\n- Follow-up: Monitor skin's reaction to treatment and reassess if not effective after three months.\\n- Consideration: Oral contraceptive as an option if topical treatment is ineffective or not tolerated.\",\n",
       "  'parsed_soap_note': {'Subjective': 'Currently in ON. Reviewed CM, [insert first initial. Last name here], SOAP note and confirmed info provided. See note for details. \\n\\n22 year old female engaging for acne concerns\\n\\nOnset: has had ance since teens, but current flare-up started 8 months ago with a gradual worsening over the past 3 months \\nLocation: Primarily to jawline and chin, with some lesions to cheeks and upper back\\nAggravating factors: \\n\\t•\\tworsens around the time of menstruation and during periods of increased stress from school\\n\\t•\\tRecently switched to a new Cerave moisturizer\\nAlleviating factors: none\\nSeverity: 15-20 inflammatory papules and pustules \\nAssociated symptoms/characteristics: \\n\\t•\\tReports some hyperpigmentation/redness to cheeks\\n\\t•\\tReports feels anxious about going out in public due to appearance of acne \\n\\nCurrent skin care routine:\\n\\t•\\tAM: Cerave foaming cleanser, moisturizer with SPF\\n\\t•\\tPM: Cerave foaming cleanser, OTC retinol serum, cerave moisturizer\\nPrevious treatments tried:\\n\\t•\\tOTC: Benzoyl peroxide 5%, salicylic acid products\\n\\t•\\tNo previous rx treatments tried\\nReproductive history:\\n\\t•\\tLMP: Nov. 28, 2024\\n\\t•\\tPregnancy concerns: None\\n\\t•\\tCurrently breastfeeding: No\\n\\t•\\tNo history of prescribed birth control use \\nRelevant history:\\n\\t•\\tNo underlying medical conditions\\n\\t•\\tCurrent medications: Multivitamin\\n\\t•\\tNKA (= abbreviation for no known allergies)',\n",
       "   'Objective': '•\\tConfirmed ID\\n\\t•\\tNAD, A+Ox3\\n\\t•\\tDressed appropriately, speaking in full sentences\\n\\t•\\tSkin photo: provide description here',\n",
       "   'Assessment': '•\\tMild to moderate papulopustular acne',\n",
       "   'Plan': 'Advised for some concerns, virtual care is not a substitute or replacement for in-person exam. Pt acknowledges this\\n\\nDifferential diagnoses discussed: Rosacea vs acne\\nTreatment plan: \\n\\t•\\tContinue with Cerave foaming cleanser. Can decrease to QHS use only and water only in am if experiencing skin dryness\\n\\t•\\tConsider changing moisturizers back to what was previously used, if no acne at the time of use. Ensure it is non-comedogenic\\n\\t•\\tDiscussed treatment options with patient - topical vs oral contraception. Pt prefers to start with topical route. Rx for Tactupump sent to pharmacy on file. Discussed Tactupump can cause skin irritation if applied too frequently. Pt to start with applying tactupump Q2-3 nights before bed and slowly increase to QHS, as tolerated. Apply moisturizer after. Pt aware it can take up to 3 months to start seeing results\\n\\nFollow up if symptoms not improving and/or resolving as expected and especially if worsening; patient can engage 24/7/365 with any concerns.'},\n",
       "  'parsed_llm_soap_note': {'Subjective': '- Chief Complaint: Acne worsening over the past few months.\\n- Duration: Gradual worsening over the last eight months, significant flare-up in the last three months.\\n- Location: Concentrated on jawline and chin, with some lesions on cheeks and upper back.\\n- Previous Episodes: Has had acne since teenage years, current episode intermittent for the past eight months.\\n- Aggravating Factors: Worse around menstrual cycle and during stress from school; possibly related to new moisturizer.\\n- Associated Symptoms: Bumps and redness on cheeks, noticeable enough to cause anxiety in public.\\n- Skin Care Routine: Uses Cerave foam cleanser, retinol serum in the evening, and moisturizer with SPF 30.\\n- Previous Treatments: Benzoyl peroxide 5% and salicylic acid products, no previous prescription treatments.\\n- Reproductive Health: Last menstrual period on November 28th, no concern about pregnancy, not breastfeeding, never been on birth control.\\n- Medications: Retinol (over the counter), multivitamin.\\n- Allergies: No known allergies.\\n- Social History: Stress from school.\\n\\nPast Medical History:\\n- No underlying medical conditions such as PCOS, elevated blood sugars, high blood pressure, or cholesterol issues.',\n",
       "   'Objective': '- N/A',\n",
       "   'Assessment': '- Moderate acne with hormonal and stress-related components.\\n- Possible rosacea component due to flushing with alcohol and exercise.',\n",
       "   'Plan': \"- Treatment: Start with a topical combination of retinoid and benzoyl peroxide (Tac tube pump). Use every other day or every three days at night, gradually increasing to nightly use as tolerated. Apply a pea-sized amount and ensure adequate moisturizing.\\n- Skin Care: Continue using non-comedogenic moisturizer and SPF 30 sunscreen.\\n- Follow-up: Monitor skin's reaction to treatment and reassess if not effective after three months.\\n- Consideration: Oral contraceptive as an option if topical treatment is ineffective or not tolerated.\"}},\n",
       " {'filename': 'Julie L Case 4.txt',\n",
       "  'language': 'french',\n",
       "  'transcription': \"Speaker Guest-1: Bonjour, Comment ça va?\\nSpeaker Guest-2: Bonjour, oui ça va bien vous même?\\nSpeaker Guest-1: Excellent oui, ça va bien. Je vais juste vous demander de vous identifier d'abord.\\nSpeaker Guest-1: Alors votre nom, prénom?\\nSpeaker Guest-2: Juliette Beauregard.\\nSpeaker Guest-1: Et votre date de naissance?\\nSpeaker Guest-2: C'est le 3 août 1980.\\nSpeaker Guest-1: 5 OK, parfait donc mon nom c'est Julie Lefebvre. Je suis infirmière praticienne. Je vous vois aujourd'hui, selon la note de l'infirmière que vous vous venez de voir au triage, vous voulez renouveler votre médication pour l'acné, le Rétinoïde qui qui s'appelle Stiva à 0.0 25 mg, c'est bien ça?\\nSpeaker Guest-1: Oui.\\nSpeaker Guest-1: C'est bien ça? Oui, oui, c'est bien ça.\\nSpeaker Guest-1: Donc c'est une crème, je voyais ça, ils font.\\nSpeaker Guest-1: Des tubes de 25 g là donc parfait oui, ça fait combien de temps que vous avez de l'acné?\\nSpeaker Guest-2: Depuis que je suis adolescente, là je pense que les hormones n'ont faite quand durant l'adolescence à comme sortie. Puis ouais, j'ai ça depuis que je suis adolescente.\\nSpeaker Guest-1: Avez-vous vu un dermatologue de depuis ce temps-là?\\nSpeaker Guest-2: Javais.eu mon médecin de famille qui m'avait suivie à ce moment-là, on avait fait 2 traitements d'acutam dans le passé.\\nSpeaker Guest-2: Puis après ces traitements d'Aquitaine, là on voit que ça s'est stabilisé tu sais. Puis juste avec la crème je suis bien là tu sais il y a des des lésions ici et là mettez, c'est vraiment léger, puis je trouve que c'est ça fait.\\nSpeaker Guest-1: Un bon résultat là OK, puis sur la crème comme telle, ça fait quelques temps que vous êtes dessus.\\nSpeaker Guest-1: Comme décané ou moi. Ouais, c'est pas d'irritation, votre poids devient pas rouge, trop sèche.\\nSpeaker Guest-2: Non non, j'ai aussi une bonne crème hydratante, c'est que ça, ça aide énormément aussi.\\nSpeaker Guest-1: Oui c'est ça exact. Puis vous utilisez pas de produit là asséchant, comme du pyroxée de de Brésil et l'eau d'autres d'autres choses. Vous avez réussi à trouver une bonne recette dans le fond.\\nSpeaker Guest-2: Là oui c'est c'est vraiment plein ça. Là je, je suis sur mon petit train d'aller là, puis la vie est belle là.\\nSpeaker Guest-1: Ok Ben génial, très très bien. Vous avez pas de lésions sur le corps? Non non, parfait. Votre pharmacie, c'est bien le Jean Coutu.\\nSpeaker Guest-1: Sur la rue Papineau.\\nSpeaker Guest-2: Oui, c'est bien ça.\\nSpeaker Guest-1: Ok très bien écoutez, puisque ça fait longtemps que vous êtes dessus, c'est bien stable, je vais vous le renouveler pour un an, comme ça vous vous allez pouvoir aller chercher là les les tubes comme comme vous le désirez. L'avantage de de des rétinoïdes ça aura un effet aussi anti rides fait que ça peut être tant mieux si vous le tolériez bien je pense qu'on va rester avec la même le même traitement, puis on va garder ça. Faites attention au soleil, c'est sûr que ça peut diminuer.\\nSpeaker Guest-1: Possibilité au soleil. J'imagine que que vous êtes déjà au courant par contre. Et puis ça ressemble à ça. Est ce que vous avez des questions de votre côté? Non pas du tout. Je suis habitué avec ce traitement là donc je le connais très bien mais non j'ai.\\nSpeaker Guest-2: Pas vraiment pas de.\\nSpeaker Guest-1: Question, ça va bien? Ben super super, je vous prescris la crème. Puis si vous avez des questions ou quoi que ce soit qui a qui a un problème, n'hésitez pas à nous recontacter.\\nSpeaker Guest-2: Parfait, merci beaucoup, merci bye.\\nSpeaker Guest-2: Bye.\\nSpeaker Guest-2: Oui.\\nSpeaker Unknown:\",\n",
       "  'soap_note': \"S: Femme de 38ans, veut faire renouveler son rétinoide, Stieva 0,025mg en crème. Le prend pour de l'acné depuis l'adolescence. A pris 2 traitements d'Accutane dans le passé avec son médecin de famille. Bien contrôlée avec Stieva qu'elle prend depuis un bon moment. Rares lésions au visage occasionnelles. Pas d'irritation, pas de lésions sur le corps. Mets une lotion hydratante, bonne routine de soins du visage.\\n\\nO: Vidéo, id\\n\\nA: Acne\\n\\nP: Stieva 0.025mg crème faxée au Jean Coutu pour un an. Médication augmente la sensibilité au soleil\",\n",
       "  'llm_soap_note': \"Subjectif:\\n- Juliette Beauregard souhaite renouveler sa médication pour l'acné, le rétinoïde Stiva à 0,025 mg.\\n- Elle a de l'acné depuis son adolescence, probablement due aux hormones.\\n- Elle a déjà suivi deux traitements d'acutam dans le passé, ce qui a stabilisé sa condition.\\n- Actuellement, elle utilise la crème Stiva avec de bons résultats, les lésions sont légères.\\n- Elle n'a pas d'irritation, de rougeur ou de sécheresse excessive grâce à une bonne crème hydratante.\\n- Elle n'utilise pas de produits asséchants comme le peroxyde de benzoyle.\\n- Pas de lésions sur le corps.\\n\\nAntécédents médicaux:\\n- A suivi deux traitements d'acutam dans le passé pour l'acné.\\n\\nObjectif:\\n- N/A\\n\\nÉvaluation:\\n- Acné stable sous traitement avec rétinoïde Stiva.\\n\\nPlan:\\n- Renouveler la prescription de la crème Stiva pour un an.\\n- Conseiller d'éviter l'exposition au soleil en raison de l'utilisation de rétinoïdes.\\n- Aucune question ou préoccupation supplémentaire de la part de la patiente.\\n- Si des questions ou des problèmes surviennent, contacter la clinique.\",\n",
       "  'parsed_soap_note': {'Subjective': \"Femme de 38ans, veut faire renouveler son rétinoide, Stieva 0,025mg en crème. Le prend pour de l'acné depuis l'adolescence. A pris 2 traitements d'Accutane dans le passé avec son médecin de famille. Bien contrôlée avec Stieva qu'elle prend depuis un bon moment. Rares lésions au visage occasionnelles. Pas d'irritation, pas de lésions sur le corps. Mets une lotion hydratante, bonne routine de soins du visage.\",\n",
       "   'Objective': 'Vidéo, id',\n",
       "   'Assessment': 'Acne',\n",
       "   'Plan': 'Stieva 0.025mg crème faxée au Jean Coutu pour un an. Médication augmente la sensibilité au soleil'},\n",
       "  'parsed_llm_soap_note': {'Plan': \"- Renouveler la prescription de la crème Stiva pour un an.\\n- Conseiller d'éviter l'exposition au soleil en raison de l'utilisation de rétinoïdes.\\n- Aucune question ou préoccupation supplémentaire de la part de la patiente.\\n- Si des questions ou des problèmes surviennent, contacter la clinique.\"}},\n",
       " {'filename': 'Julie L Case 3.txt',\n",
       "  'language': 'french',\n",
       "  'transcription': \"Speaker Guest-1: Oui Bonjour donc mon nom est Julie Lefebvre, je suis infirmière praticienne, comment je peux vous aider aujourd'hui?\\nSpeaker Guest-2: Oui Bonjour, j'ai l'impression que je fais peut-être une infection ordinaire.\\nSpeaker Guest-1: Ok, d'accord, oui, c'est Julie. En fait, les les notes de l'infirmière, je voyais que ça fait 3 jours environ que que ça brûle. Lorsque vous urinez, est-ce que vous avez d'autres symptômes? À part ça? Avez-vous de la douleur dans le bas du ventre?\\nSpeaker Guest-2: Non, j'ai pas mal au ventre.\\nSpeaker Guest-1: Non, pas de douleur dans le dos.\\nSpeaker Guest-3: Non, est ce que vous avez fait de la fièvre récemment?\\nSpeaker Guest-4: Non OK, est ce que?\\nSpeaker Guest-1: Vous avez remarqué s'il y a du sang dans l'urine?\\nSpeaker Guest-2: Non, j'ai pas vu.\\nSpeaker Guest-1: Ça non OK, est ce que vous êtes enceinte présentement?\\nSpeaker Guest-1: Non vous allez étais pas non plus non plus. Ok d'accord fait que l'informe brûle main. Pas vraiment d'autres douleurs dans le passé. Est ce que vous avez déjà fait une infection urinaire?\\nSpeaker Guest-2: Oui, et ça fait à peu près 3 ans de tout ça. J'avais à peu près les mêmes symptômes. Là, tu sais, j'avais vraiment ça, ça me brûlait quand je verrais et cetera, ça, c'était.\\nSpeaker Guest-2: Ça, c'était pas mal équivalent.\\nSpeaker Guest-1: Là, OK. Puis, quand vous aviez pris de la médication, ça avait vraiment aidé. C'était disparu. Les symptômes?\\nSpeaker Guest-2: Oui, oui, tout à fait, c'est vraiment.\\nSpeaker Guest-1: Ça d'accord. Je vois dans la note que vous vous souvenez pas quel médicament vous aviez pris la dernière fois. C'est pas très grave là, ça fait quand même 3 ans, ça fait un bon bout de temps.\\nSpeaker Guest-1: Vous avez pas d'allergie aux médicaments?\\nSpeaker Guest-2: Non, j'ai aucune allergie.\\nSpeaker Guest-1: Ok, je vois que votre pharmacie, c'est le Proxime à Québec, sur la rue Bouchard. C'est bien ça? Ouais, parfait.\\nSpeaker Guest-1: Et puis un autre question, est ce que vousavez.eu des relations non protégées récemment?\\nSpeaker Guest-1: Est ce que vous avez un conjoint stable?\\nSpeaker Guest-2: Oui, j'ai un conjoint stable. Si j'ai le même partenaire depuis 10 ans, là ça faisait longtemps. On a des relations non protégées là, mais à ce niveau-là, lui, il va sexualiser, donc on est correct.\\nSpeaker Guest-1: Ok super excellent, puis qu'au niveau vaginite vous avez avez vousdeja.eu ça, est ce que ça pourrait que ce soit ça selon vous ou avez vousdeja.eu des pertes vaginales importantes?\\nSpeaker Guest-2: Non j'ai vraiment aucun symptôme vaginal là j'ai pas de perte vaginale au du tout du tout.\\nSpeaker Guest-2: Jai.eu une vaginite là il y a à peu près, ça fait vraiment longtemps là-dessus, là une dizaine d'années facile mais c'est vraiment pas les mêmes symptômes. Ok donc j'ai vraiment aucun aucun symptôme vaginal puis.\\nSpeaker Guest-1: Pas de carreaux reins non plus.\\nSpeaker Guest-1: Non OK Ben c'est bon dans ce cas-là. Écoutez, on va commencer je vais, je vais commencer un médicament qui s'appelle la Phosphomycine. Ce qui est le fun c'est que c'est juste une dose. Alors vous une dose et c'est fini. Des fois les gens ils trouvent ça étrange là, mais c'est comme ça, ça fonctionne bien généralement.\\nSpeaker Guest-1: C'est une poudrequi.se dissout dans l'eau devait être 2 h à jeun avant de la prendre 2 h à jeun après je vais laisser le pharmacien vous vous expliquer ça.\\nSpeaker Guest-1: Normalement les symptômes devraient être disparus là 48 h après la prise du médicament. Si c'est pas disparu Reconnectez vous puis on va regarder une autre façon. Souvent quand c'est très clair comme ça que les symptômes ressemblent drôlement à une infection urinaire, on fait pas de culture d'urine, mais si on a le moindre doute là si c'est pas traité justement après la prise de phosphomicine, on va faire une culture pour être sûr à 100%. Là voir c'est quel?\\nSpeaker Guest-1: Comme qui est là? Ou s'assurer justement que c'est bel et bien une réflexion urinaire, puis pas d'autres choses. Ok ça vous va, oui ok, fait qu'on fait ça donc soit 48 h je vous dirais, on regarde par la suite, j'envoie la prescription à votre pharmacie maintenant, puis en attendant vous pouvez prendre là bien sûr du Stylet MOL ou Advil pour la douleur. OK parfait, merci beaucoup.\\nSpeaker Guest-1: Merci, bye.\\nSpeaker Guest-2: Aïe, au revoir.\\nSpeaker Unknown: \\nSpeaker Unknown:\",\n",
       "  'soap_note': \"S:Femme adulte venant pour des symptômes d'infection urinaire. Elle ressent une brûlure à la miction depuis 3 jours. Elle n'a pas de mal de ventre, pas de fièvre, pas de douleur lombaire, pas de relations sexuelles à risque, partenaire stable, pas enceinte, pas d'écoulement vaginal. Pas d'allergies aux médicaments, a eu une infection urinaire x3 ans, soulagée avec médication- ne se souvient plus laquelle. \\n\\nO: Vidéo\\n\\nA: Infection urinaire\\n\\nP: Fosfomycine 1 dose, faxée à sa pharmacie. Doit être à jeun.\",\n",
       "  'llm_soap_note': \"SOAP Note:\\n\\nSubjective:\\n- Raison de la visite: Impression d'une infection urinaire.\\n- Symptômes: Brûlure lors de la miction depuis environ 3 jours.\\n- Épisodes antérieurs: A eu une infection urinaire il y a environ 3 ans avec des symptômes similaires, traitée avec succès par médication.\\n- Impact sur les activités quotidiennes: Non mentionné.\\n- Symptômes associés: Pas de douleur abdominale, pas de douleur dorsale, pas de fièvre, pas de sang dans l'urine, pas de symptômes vaginaux.\\n\\nPast Medical History:\\n- Antécédents d'infection urinaire il y a 3 ans.\\n- Pas d'allergies médicamenteuses.\\n- Vaginite il y a environ 10 ans, mais pas de symptômes actuels similaires.\\n\\nObjective:\\n- N/A\\n\\nAssessment:\\n- Probable infection urinaire.\\n\\nPlan:\\n- Traitement: Prescription de Phosphomycine, une dose unique.\\n- Conseils: Dissoudre la poudre dans l'eau, prendre à jeun 2 heures avant et après.\\n- Suivi: Si les symptômes persistent après 48 heures, recontacter pour envisager une culture d'urine.\\n- Médication supplémentaire: Prendre du Tylenol ou Advil pour la douleur.\\n- Prescription envoyée à la pharmacie Proxime à Québec, rue Bouchard.\",\n",
       "  'parsed_soap_note': {'Subjective': \"Femme adulte venant pour des symptômes d'infection urinaire. Elle ressent une brûlure à la miction depuis 3 jours. Elle n'a pas de mal de ventre, pas de fièvre, pas de douleur lombaire, pas de relations sexuelles à risque, partenaire stable, pas enceinte, pas d'écoulement vaginal. Pas d'allergies aux médicaments, a eu une infection urinaire x3 ans, soulagée avec médication- ne se souvient plus laquelle.\",\n",
       "   'Objective': 'Vidéo',\n",
       "   'Assessment': 'Infection urinaire',\n",
       "   'Plan': 'Fosfomycine 1 dose, faxée à sa pharmacie. Doit être à jeun.'},\n",
       "  'parsed_llm_soap_note': {'Subjective': \"- Raison de la visite: Impression d'une infection urinaire.\\n- Symptômes: Brûlure lors de la miction depuis environ 3 jours.\\n- Épisodes antérieurs: A eu une infection urinaire il y a environ 3 ans avec des symptômes similaires, traitée avec succès par médication.\\n- Impact sur les activités quotidiennes: Non mentionné.\\n- Symptômes associés: Pas de douleur abdominale, pas de douleur dorsale, pas de fièvre, pas de sang dans l'urine, pas de symptômes vaginaux.\\n\\nPast Medical History:\\n- Antécédents d'infection urinaire il y a 3 ans.\\n- Pas d'allergies médicamenteuses.\\n- Vaginite il y a environ 10 ans, mais pas de symptômes actuels similaires.\",\n",
       "   'Objective': '- N/A',\n",
       "   'Assessment': '- Probable infection urinaire.',\n",
       "   'Plan': \"- Traitement: Prescription de Phosphomycine, une dose unique.\\n- Conseils: Dissoudre la poudre dans l'eau, prendre à jeun 2 heures avant et après.\\n- Suivi: Si les symptômes persistent après 48 heures, recontacter pour envisager une culture d'urine.\\n- Médication supplémentaire: Prendre du Tylenol ou Advil pour la douleur.\\n- Prescription envoyée à la pharmacie Proxime à Québec, rue Bouchard.\"}},\n",
       " {'filename': 'Julie B Case 1.txt',\n",
       "  'language': 'french',\n",
       "  'transcription': \"Speaker Guest-1: Bonjour, vous allez bien? Oui merci oui donc mon nom c'est Julie Bourque, je suis infirmière pratique spécialisée en soit une première ligne donc je viens de voir votre raison de consultation. Vous voulez consulter pour la contraception, c'est bien ça? Exactement oui et avant de commencer, est ce que je peux juste vous demander de me dire votre nom, votre date de.\\nSpeaker Guest-2: Naissance, s'il vous plaît, oui, Catherine Séguin, 1 août 1009, cent-quatre 20.\\nSpeaker Guest-2: 10. Excellent.\\nSpeaker Guest-1: Donc je comprends que vous êtes dans un endroit confidentiel à ce moment, puis tout va bien à ce niveau-là.\\nSpeaker Guest-1: Donc avant de commencer, là je vais juste prendre quelques petites informations, est-ce que vous avez un médecin?\\nSpeaker Guest-2: De famille j'en ai un oui, mais je suis pas capable de le voir.\\nSpeaker Guest-1: OK parfait est-ce que vous avez-vous avez des problèmes de santé connus?\\nSpeaker Guest-2: Non, aucun problème de santé connue.\\nSpeaker Guest-1: Parfait est-ce que vous prenez?\\nSpeaker Guest-1: Dans le fond de la, la médication, là ce que j'ai vu, c'est que vous prenez du Ractine, c'est bien ça?\\nSpeaker Guest-2: Exactement, j'en prends un compromis là pour les allergies, le matin là, mais c'est tout.\\nSpeaker Guest-2: Parfait.\\nSpeaker Guest-1: Donc c'est des allergies saisonnières ou c'est des allergies?\\nSpeaker Guest-2: Oui, c'est le pollen.\\nSpeaker Guest-2: Parfait.\\nSpeaker Guest-2: Oui.\\nSpeaker Guest-2: Est-ce que je pourrais avoir la même chose?\\nSpeaker Guest-1: Oui, on va pas regarder ça ensemble sans faute.\\nSpeaker Guest-1: Probablement qu'il y aurait pas de problème, je vais juste valider si cette médication-là vous convient. Ok parfait fait que j'ai bien lu la note de la gestion de soins que vous évaluez. Là je comprends que vous êtes une jeune femme qui aimerait une toute la contraception, que justement votre amie elle veut à l'est que dans le fond ce que je comprends aussi c'est que vous avezpas.eu encore.eu de relation sexuelle, c'est bien ça non? Jamais vous avezpas.eu de relation orale ou à risque.\\nSpeaker Guest-2: Jamais jaijamais.eu de conjoint à la date parfait.\\nSpeaker Guest-1: Donc voilà ça c'est bon donc pour commencer là j'aimerais savoir votre date dernière date de menstruation s'il vous plaît?\\nSpeaker Guest-2: C'était le.\\nSpeaker Guest-2: Le 28 novembre.\\nSpeaker Guest-1: Parfait. Votre cycle risque irrégulier? Oui, parfaitement.\\nSpeaker Guest-1: Donc à peu près une trentaine de jours. 28, 28, parfait.\\nSpeaker Guest-1: Excellent est ce que vous saignez énormément?\\nSpeaker Guest-2: Non, presque pas chanceuse.\\nSpeaker Guest-2: Parfait.\\nSpeaker Guest-1: Ça dure combien de temps?\\nSpeaker Guest-2: Ça dure 5 jours.\\nSpeaker Guest-1: Parfait est-ce que vous avez beaucoup mal au ventre?\\nSpeaker Guest-2: Non, jamais que.\\nSpeaker Guest-1: Vous faites de l'acné. Est-ce que vous avez-vous avez pas l'air de faire de l'acné quand je l'entends comme ça, mais ce qu'on.\\nSpeaker Guest-2: En fait non, j'en ai jamais fait parfait.\\nSpeaker Guest-1: Parfait.\\nSpeaker Guest-1: Ça, ça va dans la maison partagée. Est-ce que vous avez déjà fait un bilan de vitesse? J'imagine que non, vous avez pas le relation sexuelle là non, c'est ça parfait vous avezjamais.eu d'examen généthologique non plus j'imagine, non ok parfait. Est-ce que on va tomber plus dans les contre-indications? Voilà la contraception, est-ce que vous avez déjà des migraines ou des migraines avec des des des aspects visuels ajoutés des choses comme ça?\\nSpeaker Guest-1: Non.\\nSpeaker Guest-1: D'accord, est-ce que il y a des gens qui ont fait des cailloux dans dans votre famille ou vous personnellement?\\nSpeaker Guest-2: Non, pas moins, ni personne.\\nSpeaker Guest-1: D'accord, ils pour repérer récemment, vous fumez pas? Non, vous avezpas.eu des segments, c'est anormal, vous dites? Bon bah qu'est-ce qui est en ligne? Je sais pas. Qu'est-ce pourquoijai.eu ça? Et cetera, non.\\nSpeaker Guest-1: Pis je peux pas être ensemble. On comprend. Vous avez pas de cancer de Sein ou ou des maladies du foie non plus non, maladie inflammatoire intestinale connue, rien à ce mot-là diabète, l'autre pression OK, des problèmes cardiaques non plus, non ok excellent. J'ai vu dans la la conversation que le gestionnaire aussi de soins que votre réaction antérieure est à 110.\\nSpeaker Guest-1: Sur 70, ce qui est belle pression là en soi, là c'est vraiment une très belle pression. Ça, ça m'inquiète pas à ce niveau-là.\\nSpeaker Guest-1: Votre poids, votre taille, environ là.\\nSpeaker Guest-2: Un cent-dix livres et je mesure 5 pieds.\\nSpeaker Guest-2: D'accord?\\nSpeaker Guest-1: Donc excellent. En soit, vous avez pas de contre-indication à la contraception en soi, c'est sûr qu'on peut la débuter là à tout moment à ce niveau-là. Est-ce que votre choix était vraiment définitif? Parce que y a différentes.\\nSpeaker Guest-2: Je vais faire comme mon ami.\\nSpeaker Guest-1: Excellent donc c'est important de de l'apprendre à la même heure tout le temps pour éviter les oublies. Parce que certainement si vous oubliez puis vous avez-vous êtes actifs sexuellement, Ben ça peut avoir un impact. Vous pouvez tomber enceinte littéralement ça protège pas des ITS à ce moment-là donc il faut vraiment mettre le Condom.\\nSpeaker Guest-1: Si jamais vous alliez une relation sexuelle et vous avez oublié votre.\\nSpeaker Guest-1: Votre pilule en fait, à ce niveau-là, je vais vous envoyer un document là qui vous explique vraiment comment quoi faire et cetera, dépendamment ça fait combien de temps que vous l'oubliez et tout le tralala. Il existe le plan B Si jamais ça fait longtemps que vous avez pas pris votre pilule, et cetera, c'est clairement pas à titre préventif, mais si jamais il y aurait quelque chose à ce niveau-là, mais ça peut éviter qu'on est ensemble. Fait que je vais vous envoyer la documentation à ce niveau-là dans le chat après notre conversation.\\nSpeaker Guest-2: D'accord?\\nSpeaker Guest-1: Donc le test pas en tant que tel. Ben écoutez, pour l'instant vous avez pas besoin. Certainement va faire reçu votre médecin de famille lorsque vous allez devenir actif sexuellement. Je pense que ça serait une bonne idée.\\nSpeaker Guest-1: Si vous avez des douleurs à me donner à l'importante et douleurs thoraciques, essoufflement, vous crachez du sang, du sang, des maux de tête épouvantables à ce moment-là faut vraiment consulter rapidement. Là à l'urgence, là c'est vraiment important des problèmes de vision des choses comme ça. Là c'est des choses pour arriver mais c'est très rare. Mais si jamais c'est arrivé pour me reconsulter à ce niveau-là.\\nSpeaker Guest-1: Je sais pas si ça répond un peu bien aux questions.\\nSpeaker Guest-2: À si vous voulez bien, oui, oui.\\nSpeaker Guest-1: Au niveau des la télé, mais c'est sûr que au niveau des effets secondaires, ça ça varie d'une personne à une autre. Des fois c'est plusieurs essais, savoir la bonne pilule, voir des petits effets secondaires au niveau des saignements, ça peut différer un petit peu des mots de tête. Donc tu sais ça peut jouer sur différents niveaux, le poids et cetera. Donc faut vraiment je pense voir quel meilleur pilule est la l'autre on essaie à l'Est, c'est un bon, une bonne pilule en soi, si jamais vous avez-vous voyez des des changements, et cetera. Ben à ce niveau-là.\\nSpeaker Guest-1: Simplement reconsulté on peut-on peut tout simplement changer. Bruno, si ça fait pas pour vous, je vais vous envoyer aussi un pamphlet avec le toute la documentation sur les effets secondaires surveillés. Un effet secondaire, c'est pas quelque chose de néfaste, de dangereux, mais des fois c'est tannant, c'est quelque chose qui est tannant, qui peut arriver, qui est tannant. Puis, si ça vient trop engendrer un impact sur votre vie, mais à ce moment-là, on peut ajouter la médication avec le taux d'hormones que vous voulez, ça marche? Oui, c'est parfait.\\nSpeaker Guest-1: Excellent donc écoutez, je vais vous envoyer ça la pharmacie.\\nSpeaker Guest-1: Et dans le fond on peut prévoir un rendez-vous de suivi dans 3 mois puis pour simplement le renouveler à ce moment-là, voir Comment ça va, combien?\\nSpeaker Guest-2: C'est parfait, oui, parfait. Parfait, merci.\\nSpeaker Guest-2: Bye.\\nSpeaker Guest-1: Et ce que je ferme?\\nSpeaker Guest-1: Puis.\\nSpeaker Unknown: \\nSpeaker Unknown:\",\n",
       "  'soap_note': 'Entrevue en télé consultation\\nEndroit confidentiel\\nDouble identification du patient confirmé avec photo Limite d’une téléconsultation expliquée\\nMdf: oui, incapable de le voir\\nATCD: aucun\\nMdx: Reactine id le matin\\nAllergie: pollen, pas d’allergie aux médicaments\\nS:\\nDésire débuter contraception en prévision relation sexuelle Intéressée par Alesse, comme son amie\\nContraceptions antérieures: NIL\\nDDM: 28 nov\\nCycle: régulier Durée:28 jours\\nFlux menstruel: leger Durée: 5 jours\\nDysménorrhée: non\\nAcné: non\\nActivité sexuelle: nil, aucune\\nNbr de partenaires dans les 3 derniers mois/année: non Relations sexuelles protégées : non\\nDépistage ITSS ; non\\nDernier examen gynéco/Pap test: NON\\nØ atcd de migraine ni migraine avec aura\\nØ Thromboembolie veineuse personnelle ni familiale\\nØ chx récente\\nØ Tabagisme\\nØ Saignement vaginal anormal de cause inconnue\\nØ Grossesse soupçonnée\\nØ Cancer sein et de Ø Maladie hépatique active\\nØ lupus\\nØ MII connu\\nØ Diabète compliqué ou ø HTA mal contrôlée\\nØ MCAS/AVC/insuffisance cardiaque/valvulopathie compliquée\\nO: vidéo\\nAttitude collaborative. Eupnéique.\\n \\nTA: 110-70\\nPoids: 110 lbs Taille: 5pied\\nA: début de contraception Pas de C-I à la COC\\nPlan :\\nRx: alesse die x 3 mois\\nRevoir dans 3 mois pour suivi e-s\\nEffets 2nd expliqués et documentation donnée sur le sujet\\nCounselling sur utilisation/oubli/irrégularité des saignements les premiers mois ; document envoyé sur le sujet\\nPlan B discuté\\nCondom a utiliser pour protéger ITSS\\nCounselling ITSS\\nDépistage ITSS\\nPap test à faire lorsqu active sexuellement\\nConsulter à l’urgence si douleur abdominale importante, douleur thoracique importante (avec ou sans dyspnée), céphalée sévère (avec ou sans étourdissements, sensation de faiblesse, et engourdissement latéralisé). Problème de vision (perte de vision, vision embrouillée latéralisée ou non). Trouble du langage. Douleur, rougeur, oedème important dans un membre inférieur (cuisse ou mollet).\\nComprend bien, en accord, aucune question',\n",
       "  'llm_soap_note': \"SOAP Note:\\n\\nSubjectif:\\n- Consultation pour la contraception.\\n- Pas de relations sexuelles antérieures, ni orales ni à risque.\\n- Dernière menstruation le 28 novembre, cycle régulier de 28 jours, saignements légers durant 5 jours, pas de douleurs abdominales, pas d'acné.\\n- Pas de migraines, ni d'antécédents familiaux de caillots sanguins.\\n- Ne fume pas, pas de symptômes anormaux, pas de cancer du sein, maladies du foie, maladies inflammatoires intestinales, diabète, hypertension ou problèmes cardiaques.\\n\\nAntécédents médicaux:\\n- Aucun problème de santé connu.\\n- Prend du Ractine pour les allergies saisonnières au pollen.\\n- Tension artérielle de 110/70, poids de 110 livres, taille de 5 pieds.\\n\\nObjectif:\\n- N/A\\n\\nÉvaluation:\\n- Pas de contre-indications à la contraception.\\n\\nPlan:\\n- Prescription de contraception orale.\\n- Envoi d'un document explicatif sur l'utilisation de la pilule contraceptive et le plan B.\\n- Conseils sur l'importance de prendre la pilule à la même heure chaque jour et l'utilisation de préservatifs pour la protection contre les ITS.\\n- Suivi prévu dans 3 mois pour évaluer la tolérance et renouveler la prescription si nécessaire.\\n- Envoi d'un pamphlet sur les effets secondaires possibles de la contraception.\",\n",
       "  'parsed_soap_note': {'Subjective': 'Désire débuter contraception en prévision relation sexuelle Intéressée par Alesse, comme son amie\\nContraceptions antérieures: NIL\\nDDM: 28 nov\\nCycle: régulier Durée:28 jours\\nFlux menstruel: leger Durée: 5 jours\\nDysménorrhée: non\\nAcné: non\\nActivité sexuelle: nil, aucune\\nNbr de partenaires dans les 3 derniers mois/année: non Relations sexuelles protégées : non\\nDépistage ITSS ; non\\nDernier examen gynéco/Pap test: NON\\nØ atcd de migraine ni migraine avec aura\\nØ Thromboembolie veineuse personnelle ni familiale\\nØ chx récente\\nØ Tabagisme\\nØ Saignement vaginal anormal de cause inconnue\\nØ Grossesse soupçonnée\\nØ Cancer sein et de Ø Maladie hépatique active\\nØ lupus\\nØ MII connu\\nØ Diabète compliqué ou ø HTA mal contrôlée\\nØ MCAS/AVC/insuffisance cardiaque/valvulopathie compliquée',\n",
       "   'Objective': 'vidéo\\nAttitude collaborative. Eupnéique.\\n \\nTA: 110-70\\nPoids: 110 lbs Taille: 5pied',\n",
       "   'Assessment': 'début de contraception Pas de C-I à la COC\\nPlan :\\nRx: alesse die x 3 mois\\nRevoir dans 3 mois pour suivi e-s\\nEffets 2nd expliqués et documentation donnée sur le sujet\\nCounselling sur utilisation/oubli/irrégularité des saignements les premiers mois ; document envoyé sur le sujet\\nPlan B discuté\\nCondom a utiliser pour protéger ITSS\\nCounselling ITSS\\nDépistage ITSS\\nPap test à faire lorsqu active sexuellement\\nConsulter à l’urgence si douleur abdominale importante, douleur thoracique importante (avec ou sans dyspnée), céphalée sévère (avec ou sans étourdissements, sensation de faiblesse, et engourdissement latéralisé). Problème de vision (perte de vision, vision embrouillée latéralisée ou non). Trouble du langage. Douleur, rougeur, oedème important dans un membre inférieur (cuisse ou mollet).\\nComprend bien, en accord, aucune question'},\n",
       "  'parsed_llm_soap_note': {'Plan': \"- Prescription de contraception orale.\\n- Envoi d'un document explicatif sur l'utilisation de la pilule contraceptive et le plan B.\\n- Conseils sur l'importance de prendre la pilule à la même heure chaque jour et l'utilisation de préservatifs pour la protection contre les ITS.\\n- Suivi prévu dans 3 mois pour évaluer la tolérance et renouveler la prescription si nécessaire.\\n- Envoi d'un pamphlet sur les effets secondaires possibles de la contraception.\"}},\n",
       " {'filename': 'Julie B Case 2.txt',\n",
       "  'language': 'french',\n",
       "  'transcription': \"Speaker Guest-1: Bonjour, vous allez bien? Oui merci oui Bonjour mon nom est Julie bourque, je suis infirmière pratique spécialisée, on souhaite de première ligne donc je constate que vous consultez aujourd'hui pour un dépissage d'infections transmis sexuellement. C'est bien ça?\\nSpeaker Guest-2: Oui exact en fait j'ai une relation non protégée là. Puis j'aimerais ça faire le test. Excellent donc.\\nSpeaker Guest-1: Avant de commencer je vais juste valider vos informations donc est ce que je peux avoir votre nom, votre date de naissance s'il vous plait?\\nSpeaker Guest-2: Oui, Julie côté, le 1 mai 1996.\\nSpeaker Guest-1: Excellent donc vous êtes dans un endroit confidentiel. Je peux le voir avant de commencer, est ce que vous avez un.\\nSpeaker Guest-1: Médecin de famille? Non, j'en ai pas d'accord. À vous de prendre la santé de santé connue.\\nSpeaker Guest-2: Non, rien, non est.\\nSpeaker Guest-1: Ce que vous prenez la médication, je pense, vous prenez à l'Est, c'est bien.\\nSpeaker Guest-2: Ça oui, je prends ça pour comme contraception.\\nSpeaker Guest-1: Parfait avec des allergies, non? Excellent. Donc j'ai vu la note de l'infirmière là que vous avez parlé avant. Donc je comprends que vousavez.eu une relation non protégée il y a 2 semaines avec un nouveau partenaire là que un nouveau chum là avec lequel vous êtes exclusif depuis un mois, oui.\\nSpeaker Guest-2: C'est.\\nSpeaker Guest-1: Ça donc, vous êtes sous Alex, puis vous vous le prenez bien, vous l'oubliez pas. C'est ce que je comprends là. Non, je l'oublie jamais.\\nSpeaker Guest-1: Parfait. Puis vous avez juste un partenaire dans les derniers dans les derniers 3 mois. Si je comprends? Oui, c'est ça parfait. C'est une relation vaginale que vous avez eue avec lui à ce moment-là? Oui, excellent.\\nSpeaker Guest-1: Au niveau des habitudes de vie, est ce que vous prenez alcool, tabac, drogue?\\nSpeaker Guest-2: Non, rien de seulement.\\nSpeaker Guest-1: Ok, parfait.\\nSpeaker Guest-1: D'accord.\\nSpeaker Guest-1: Parfait. Et dans le fond, est ce que vous avez des symptômes? Est ce que vousavez.eu des écoulements vaginaux? Ma date j'ai pas de symptômes d'accord, vous avez duré un peu plus souvent dans les urines non plus non, la fièvre, des frissons non, vous avezpas.eu de lésions non plus qui sont apparues, des petits boutons ou quelque chose au niveau-là des ulcères non, vous avezpas.eu mal au ventre non plus.\\nSpeaker Guest-2: Non plus.\\nSpeaker Guest-2: Non?\\nSpeaker Guest-1: Puis votre partenaire, lui, il y a aucun symptôme non plus.\\nSpeaker Guest-2: Non, oui, non.\\nSpeaker Guest-2: OK.\\nSpeaker Guest-1: Puis votre dernier dépistage DSS remonte à Cannes.\\nSpeaker Guest-2: My God, c'était mon chum d'avant, là ça faisait 2 ans je pense.\\nSpeaker Guest-1: D'accord, jaijamais.eu le DSS dans le passé, non.\\nSpeaker Guest-1: De savon parfait. Excellent. Donc dans le fond, ce qu'on peut faire en ce moment-ci, c'est de vraiment faire une un dépistage en soi. Est-ce que vous souhaitez faire comme tout le dépistage au grand complet VIH hépatite.\\nSpeaker Guest-2: Ça fait longtemps que je l'ai pas faite.\\nSpeaker Guest-1: Voilà donc clairement, Ben il faut utiliser le Condom là à tout moment, à ce moment-ci là, le temps qu'on a, les résultats certainement, et même après.\\nSpeaker Guest-1: Donc on va faire le bilan ensemble, puis on va.se revoir par la suite pour discuter des résultats, puis voir par la suite là s'il y a d'autres contacts à risque, et cetera.\\nSpeaker Guest-1: Je vous conseillerais aussi à votre partenaire de faire la même chose également.\\nSpeaker Guest-1: Donc vous portez un un condo en tout temps? La la LA contraception vous l'avez pas oublié, mais si jamais c'est vous l'avez oublié. Si c'est important de me le dire hein. Parce que clairement le Condom si on le venait pas, Ben effectivement on a on ajoute les risques de grossesse non désirés en plus si on on oublie la pilule donc c'est vraiment important. Donc on va savoir pour discuter des résultats par la suite.\\nSpeaker Guest-1: Si jamais vous développez des symptômes, donc si jamais vous avez mal au ventre, vous avez des signes écoulman vos vaginales ou des choses comme ça.\\nSpeaker Guest-1: C'est important d'important nous, de reconsulter rapidement des symptômes urinaires, des choses comme ça, donc c'est vraiment vraiment important de consulter avant rapidement.\\nSpeaker Guest-1: Pour faire les démarches appropriées à ce niveau-là.\\nSpeaker Guest-1: Donc à ce moment-là je vais vous renvoyer la réquisition de laboratoire avec les tests demandés vous allez faire le plus rapidement possible certainement.\\nSpeaker Guest-1: Et à ce moment-là, si jamais vous avez aucune nouvelle de notre part, on se dirait là une semaine après. En fait les tests reconnectez vous sur l'application à ce moment-là pour qu'on puisse faire le suivi avec vous là des tests que vous avez demandé à ce moment-là et qu'on puisse aller voir où cequi.se passe, pourquoi on apporte sur rien? Et cetera, ça marche.\\nSpeaker Guest-2: Oui, c'est bien.\\nSpeaker Guest-1: Excellent la même chose si jamais votre partenaire.\\nSpeaker Guest-1: Est déclaré positif à une TSS Ben Reconnectez vous rapidement qu'on puisse à ce moment-là vous traiter parfait. Donc ça fonctionne. Oui c'est Patrick question et des choses qui étaient pas claires.\\nSpeaker Guest-2: Pour vous, non, tout est beau.\\nSpeaker Guest-1: Parfait, excellent donc je vous envoie ça là à l'instant et on fera le suivi dès que possible, dès qu'on a les résultats ensemble.\\nSpeaker Guest-1: Oui, merci, plaisir, au revoir, bye.\\nSpeaker Unknown: \\nSpeaker Unknown:\",\n",
       "  'soap_note': \"Entrevue en télé consultation\\nEndroit confidentiel\\nDouble identification du patient confirmé avec carte identité Limite d’une téléconsultation expliquée\\nMdf: NIL ATCD: NIL Mdx: Alesse ID Allergie: NIL\\nHDV -Tabac/alcool/drogues ; NIL\\nS:\\nVoir note GS\\n1 relation non protégé il y a 2 semaines avec nouveau partenaire exclusif depuis 1 mois Sous COC, bonne observance\\nNbr de partenaires dans les 3 derniers mois/années: 1 partenaire dans les derniers mois Relations non-protégées; 1 fois\\nRelations orales, vaginales et anales ; relation vaginale\\nDésire dépistage ITSS\\nØ écoulement urétral Ø pollakiurie\\nØ hématurie\\nØ fièvre/frissons\\nØ lésions génitales Ø dlr abdo/pelvienne\\nContact ITSS: aucun\\nPartenaire sans symptômes, sans ITSS déclaré Dernier dépistage ITSS: il y a 2 ans\\nATCD ITSS: NIL\\nO: vidéo\\nAttitude collaborative.\\nA: r/o ITSS\\nP:\\nDiscussion et conseils\\nBilan ITSS à faire\\nS'assurer de porter le condoms en tout temps pour prévenir grossesse et ITSS\\nSuivi: selon résultats ou avant PRN\\nSe connecter si aucune nouvelle 1 semaine après avoir fait le bilan\\nConsulter si sx urinaire, leucorrhée, fièvre, saignement anormal ou si partenaire est déclaré positif à une ITSS\\nComprend bien, en accord\",\n",
       "  'llm_soap_note': \"SOAP Note:\\n\\nSubjectif:\\n- Raison de la visite: Dépistage d'infections transmissibles sexuellement (ITS) suite à une relation non protégée.\\n- Contexte: Relation non protégée il y a 2 semaines avec un nouveau partenaire exclusif depuis un mois.\\n- Symptômes associés: Aucun symptôme signalé (pas d'écoulements vaginaux, pas de douleur urinaire, pas de fièvre, pas de frissons, pas de lésions, pas de douleur abdominale).\\n- Impact sur les activités quotidiennes: Non mentionné.\\n\\nAntécédents médicaux:\\n- Médication: Prend Alesse pour la contraception.\\n- Allergies: Aucune.\\n- Antécédents sociaux: Ne consomme pas d'alcool, de tabac ou de drogues.\\n- Antécédents familiaux: Non mentionné.\\n- Antécédents d'exposition: Dernier dépistage ITS il y a environ 2 ans, jamais eu d'ITS dans le passé.\\n- Statut d'immunisation: Non mentionné.\\n\\nObjectif:\\n- N/A\\n\\nÉvaluation:\\n- Pas de symptômes actuels d'ITS.\\n- Dernier dépistage ITS il y a 2 ans.\\n\\nPlan:\\n- Investigations planifiées: Dépistage complet des ITS incluant VIH et hépatite.\\n- Conseils: Utilisation de préservatifs recommandée jusqu'à obtention des résultats et même après.\\n- Suivi: Revoir les résultats des tests et discuter des prochaines étapes. Conseiller au partenaire de faire un dépistage également.\\n- Instructions supplémentaires: Reconsulter rapidement en cas de développement de symptômes (douleur abdominale, écoulements vaginaux, symptômes urinaires).\\n- Envoi de la réquisition de laboratoire pour effectuer les tests dès que possible. Suivi des résultats via l'application une semaine après les tests.\",\n",
       "  'parsed_soap_note': {'Subjective': 'Voir note GS\\n1 relation non protégé il y a 2 semaines avec nouveau partenaire exclusif depuis 1 mois Sous COC, bonne observance\\nNbr de partenaires dans les 3 derniers mois/années: 1 partenaire dans les derniers mois Relations non-protégées; 1 fois\\nRelations orales, vaginales et anales ; relation vaginale\\nDésire dépistage ITSS\\nØ écoulement urétral Ø pollakiurie\\nØ hématurie\\nØ fièvre/frissons\\nØ lésions génitales Ø dlr abdo/pelvienne\\nContact ITSS: aucun\\nPartenaire sans symptômes, sans ITSS déclaré Dernier dépistage ITSS: il y a 2 ans\\nATCD ITSS: NIL',\n",
       "   'Objective': 'vidéo\\nAttitude collaborative.',\n",
       "   'Assessment': 'r/o ITSS',\n",
       "   'Plan': \"Discussion et conseils\\nBilan ITSS à faire\\nS'assurer de porter le condoms en tout temps pour prévenir grossesse et ITSS\\nSuivi: selon résultats ou avant PRN\\nSe connecter si aucune nouvelle 1 semaine après avoir fait le bilan\\nConsulter si sx urinaire, leucorrhée, fièvre, saignement anormal ou si partenaire est déclaré positif à une ITSS\\nComprend bien, en accord\"},\n",
       "  'parsed_llm_soap_note': {'Plan': \"- Investigations planifiées: Dépistage complet des ITS incluant VIH et hépatite.\\n- Conseils: Utilisation de préservatifs recommandée jusqu'à obtention des résultats et même après.\\n- Suivi: Revoir les résultats des tests et discuter des prochaines étapes. Conseiller au partenaire de faire un dépistage également.\\n- Instructions supplémentaires: Reconsulter rapidement en cas de développement de symptômes (douleur abdominale, écoulements vaginaux, symptômes urinaires).\\n- Envoi de la réquisition de laboratoire pour effectuer les tests dès que possible. Suivi des résultats via l'application une semaine après les tests.\"}}]"
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "records"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "def compute_bootstrap_confidence_intervals_per_section(records, n_samples=1000, ci=0.95):\n",
    "    rouge = Rouge()\n",
    "    sections = ['Subjective', 'Objective', 'Assessment', 'Plan']\n",
    "    scores = {section: {'rouge-1': [], 'rouge-2': [], 'rouge-l': []} for section in sections}\n",
    "\n",
    "    n = len(records)\n",
    "    for _ in range(n_samples):\n",
    "        sample = resample(records, n_samples=n, replace=True)\n",
    "        for section in sections:\n",
    "            sample_hyps = []\n",
    "            sample_refs = []\n",
    "            for entry in sample:\n",
    "                hyp = entry['parsed_llm_soap_note'].get(section, '').strip()\n",
    "                ref = entry['parsed_soap_note'].get(section, '').strip()\n",
    "                # Only include non-empty hypotheses and references\n",
    "                if hyp and ref:\n",
    "                    sample_hyps.append(hyp)\n",
    "                    sample_refs.append(ref)\n",
    "            # Check if we have valid pairs before computing ROUGE scores\n",
    "            if sample_hyps and sample_refs:\n",
    "                try:\n",
    "                    score = rouge.get_scores(sample_hyps, sample_refs, avg=True)\n",
    "                    for metric in ['rouge-1', 'rouge-2', 'rouge-l']:\n",
    "                        scores[section][metric].append(score[metric]['f'])\n",
    "                except ValueError as e:\n",
    "                    print(f\"Error computing ROUGE for section '{section}': {e}\")\n",
    "                    pass\n",
    "            else:\n",
    "                # No valid pairs to compute ROUGE scores\n",
    "                pass\n",
    "\n",
    "    lower_percentile = ((1.0 - ci) / 2.0) * 100\n",
    "    upper_percentile = (ci + ((1.0 - ci) / 2.0)) * 100\n",
    "    results = {}\n",
    "    for section in sections:\n",
    "        results[section] = {}\n",
    "        for metric in ['rouge-1', 'rouge-2', 'rouge-l']:\n",
    "            if scores[section][metric]:\n",
    "                lower_bound = max(0.0, np.percentile(scores[section][metric], lower_percentile))\n",
    "                upper_bound = min(1.0, np.percentile(scores[section][metric], upper_percentile))\n",
    "                results[section][metric] = {\n",
    "                    'metric': metric.replace('rouge-', 'Rouge-').capitalize(),\n",
    "                    'lower_bound': round(lower_bound, 4),\n",
    "                    'upper_bound': round(upper_bound, 4)\n",
    "                }\n",
    "            else:\n",
    "                # If no scores were accumulated for this metric and section\n",
    "                results[section][metric] = {\n",
    "                    'metric': metric.replace('rouge-', 'Rouge-').capitalize(),\n",
    "                    'lower_bound': None,\n",
    "                    'upper_bound': None\n",
    "                }\n",
    "    return results\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{\n",
      "  \"Subjective\": {\n",
      "    \"rouge-1\": {\n",
      "      \"metric\": \"Rouge-1\",\n",
      "      \"lower_bound\": 0.3226,\n",
      "      \"upper_bound\": 0.412\n",
      "    },\n",
      "    \"rouge-2\": {\n",
      "      \"metric\": \"Rouge-2\",\n",
      "      \"lower_bound\": 0.1089,\n",
      "      \"upper_bound\": 0.1593\n",
      "    },\n",
      "    \"rouge-l\": {\n",
      "      \"metric\": \"Rouge-l\",\n",
      "      \"lower_bound\": 0.3071,\n",
      "      \"upper_bound\": 0.3684\n",
      "    }\n",
      "  },\n",
      "  \"Objective\": {\n",
      "    \"rouge-1\": {\n",
      "      \"metric\": \"Rouge-1\",\n",
      "      \"lower_bound\": 0.0,\n",
      "      \"upper_bound\": 0.313\n",
      "    },\n",
      "    \"rouge-2\": {\n",
      "      \"metric\": \"Rouge-2\",\n",
      "      \"lower_bound\": 0.0,\n",
      "      \"upper_bound\": 0.1674\n",
      "    },\n",
      "    \"rouge-l\": {\n",
      "      \"metric\": \"Rouge-l\",\n",
      "      \"lower_bound\": 0.0,\n",
      "      \"upper_bound\": 0.2957\n",
      "    }\n",
      "  },\n",
      "  \"Assessment\": {\n",
      "    \"rouge-1\": {\n",
      "      \"metric\": \"Rouge-1\",\n",
      "      \"lower_bound\": 0.0833,\n",
      "      \"upper_bound\": 0.3088\n",
      "    },\n",
      "    \"rouge-2\": {\n",
      "      \"metric\": \"Rouge-2\",\n",
      "      \"lower_bound\": 0.0,\n",
      "      \"upper_bound\": 0.0536\n",
      "    },\n",
      "    \"rouge-l\": {\n",
      "      \"metric\": \"Rouge-l\",\n",
      "      \"lower_bound\": 0.0833,\n",
      "      \"upper_bound\": 0.2828\n",
      "    }\n",
      "  },\n",
      "  \"Plan\": {\n",
      "    \"rouge-1\": {\n",
      "      \"metric\": \"Rouge-1\",\n",
      "      \"lower_bound\": 0.1889,\n",
      "      \"upper_bound\": 0.2821\n",
      "    },\n",
      "    \"rouge-2\": {\n",
      "      \"metric\": \"Rouge-2\",\n",
      "      \"lower_bound\": 0.0284,\n",
      "      \"upper_bound\": 0.0859\n",
      "    },\n",
      "    \"rouge-l\": {\n",
      "      \"metric\": \"Rouge-l\",\n",
      "      \"lower_bound\": 0.171,\n",
      "      \"upper_bound\": 0.2654\n",
      "    }\n",
      "  }\n",
      "}\n"
     ]
    }
   ],
   "source": [
    "ci_results = compute_bootstrap_confidence_intervals_per_section(records)\n",
    "\n",
    "# Output the results as JSON\n",
    "json_output = json.dumps(ci_results, indent=2)\n",
    "print(json_output)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'Subjective': {'rouge-1': {'metric': 'Rouge-1',\n",
       "   'lower_bound': np.float64(0.3226),\n",
       "   'upper_bound': np.float64(0.412)},\n",
       "  'rouge-2': {'metric': 'Rouge-2',\n",
       "   'lower_bound': np.float64(0.1089),\n",
       "   'upper_bound': np.float64(0.1593)},\n",
       "  'rouge-l': {'metric': 'Rouge-l',\n",
       "   'lower_bound': np.float64(0.3071),\n",
       "   'upper_bound': np.float64(0.3684)}},\n",
       " 'Objective': {'rouge-1': {'metric': 'Rouge-1',\n",
       "   'lower_bound': 0.0,\n",
       "   'upper_bound': np.float64(0.313)},\n",
       "  'rouge-2': {'metric': 'Rouge-2',\n",
       "   'lower_bound': 0.0,\n",
       "   'upper_bound': np.float64(0.1674)},\n",
       "  'rouge-l': {'metric': 'Rouge-l',\n",
       "   'lower_bound': 0.0,\n",
       "   'upper_bound': np.float64(0.2957)}},\n",
       " 'Assessment': {'rouge-1': {'metric': 'Rouge-1',\n",
       "   'lower_bound': np.float64(0.0833),\n",
       "   'upper_bound': np.float64(0.3088)},\n",
       "  'rouge-2': {'metric': 'Rouge-2',\n",
       "   'lower_bound': 0.0,\n",
       "   'upper_bound': np.float64(0.0536)},\n",
       "  'rouge-l': {'metric': 'Rouge-l',\n",
       "   'lower_bound': np.float64(0.0833),\n",
       "   'upper_bound': np.float64(0.2828)}},\n",
       " 'Plan': {'rouge-1': {'metric': 'Rouge-1',\n",
       "   'lower_bound': np.float64(0.1889),\n",
       "   'upper_bound': np.float64(0.2821)},\n",
       "  'rouge-2': {'metric': 'Rouge-2',\n",
       "   'lower_bound': np.float64(0.0284),\n",
       "   'upper_bound': np.float64(0.0859)},\n",
       "  'rouge-l': {'metric': 'Rouge-l',\n",
       "   'lower_bound': np.float64(0.171),\n",
       "   'upper_bound': np.float64(0.2654)}}}"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "ci_results"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 800x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Plotting\n",
    "fig, ax = plt.subplots(figsize=(8, 6))\n",
    "\n",
    "# Define colors and markers\n",
    "colors = ['red', 'blue', 'green', 'purple']\n",
    "\n",
    "# Data format: (metric_name, (lower_bound, upper_bound))\n",
    "for idx, (section, metrics) in enumerate(ci_results.items()):\n",
    "    for metric_idx, (metric, bounds) in enumerate(metrics.items()):\n",
    "        lower = bounds[\"lower_bound\"] * 100  # Convert to percentage\n",
    "        upper = bounds[\"upper_bound\"] * 100  # Convert to percentage\n",
    "        x = (lower + upper) / 2\n",
    "        y = idx * 3 + metric_idx  # Spread out sections and metrics\n",
    "\n",
    "        ax.errorbar(\n",
    "            x, y, xerr=[(upper - lower) / 2], fmt='o',\n",
    "            color=colors[idx], markersize=8,\n",
    "            label=f\"{section} {metric}\" if metric_idx == 0 else \"\"\n",
    "        )\n",
    "\n",
    "        # Annotate the plot with lower and upper values if they are >= 10%\n",
    "        if lower >= 10:\n",
    "            ax.annotate(f'{lower:.1f}%', (lower, y), textcoords=\"offset points\", xytext=(-30, -2), ha='right', fontsize=8)\n",
    "        if upper >= 10:\n",
    "            ax.annotate(f'{upper:.1f}%', (upper, y), textcoords=\"offset points\", xytext=(30, -2), ha='left', fontsize=8)\n",
    "\n",
    "# Adding details to the chart\n",
    "ax.set_yticks(range(len(ci_results) * 3))\n",
    "ax.set_yticklabels([f\"{section} {metric}\" for section in ci_results for metric in ci_results[section]], fontsize=10)\n",
    "ax.set_xlabel('Rouge Scores (%)', fontsize=12)\n",
    "ax.set_title('ROUGE Score Confidence Intervals (%)', fontsize=14)\n",
    "ax.grid(True, linestyle='--', alpha=0.7)\n",
    "\n",
    "# Set x-axis limits to percentage\n",
    "ax.set_xlim(0, 100)\n",
    "\n",
    "# Adjust the legend placement\n",
    "ax.legend(loc='upper center', bbox_to_anchor=(0.5, -0.15), ncol=2, fontsize=10, frameon=False)\n",
    "\n",
    "plt.tight_layout(pad=3)\n",
    "plt.show()"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "undefined.undefined.undefined"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
